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ABSTRACT OF DISSERTATION 
 
 
A MARKOV TRANSITION MODEL TO DEMENTIA  
WITH DEATH AS A COMPETING EVENT  
 
    The research on multi-state Markov transition model is motivated by the nature of the 
longitudinal data from the Nun Study (Snowdon, 1997), and similar information on the 
BRAiNS cohort (Salazar, 2004). Our goal is to develop a flexible methodology for 
handling the categorical longitudinal responses and competing risks time-to-event that 
characterizes the features of the data for research on dementia. To do so, we treat the 
survival from death as a continuous variable rather than defining death as a competing 
absorbing state to dementia. We assume that within each subject the survival component 
and the Markov process are linked by a shared latent random effect, and moreover, these 
two pieces are conditionally independent given the random effect and their corresponding 
predictor variables. The problem of the dependence among observations made on the 
same subject (repeated measurements) is addressed by assuming a first order Markovian 
dependence structure.  
    A closed-form expression for the individual and thus overall conditional marginal 
likelihood function is derived, which we can evaluate numerically to produce the 
maximum likelihood estimates for the unknown parameters. This method can be 
implemented using standard statistical software such as SAS Proc Nlmixed©. We present 
the results of simulation studies designed to show how the model’s ability to accurately 
estimate the parameters can be affected by the distributional form of the survival term.  
    Then we focus on addressing the problem by accommodating the residual life time of 
the subject’s confounding in the nonhomogeneous chain. The convergence status of the 
chain is examined and the formulation of the absorption statistics is derived.  We propose 
using the Delta method to estimate the variance terms for construction of confidence 
intervals. The results are illustrated with applications to the Nun Study data in details.  
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Chapter 1 : Introduction 
 
1.1 Background 
In longitudinal studies it is common that repeated measurements on a response, an 
observation on a possibly censored time-to-event, and additional covariate information 
are collected on each participant. In most medical research interest often focuses on 
modeling and interpreting the interrelationships among these variables. A familiar 
example is that of studies on progression to dementia, covariates including demographic 
information, such as age, education level, and some gene-related factor, are recorded at 
baseline, and the outcome variable of interest is a series of correlated categorical 
responses which are observed at certain time points, sometimes several years apart. Time 
to progression to death is also recorded for each participant, although some subjects may 
fail to experience the event (“dementia” or “death”) by the time the study closes. The 
primary objectives of the study are (i) to understand within-subject patterns of transition 
among pre-disease states and dementia; (ii) to characterize the relationship between the 
risk of developing dementia across the long-term trajectory from time to death.  
However, addressing these objectives in practice is much more difficult depending on the 
nature of the data actually observed. The complications posed by the realities and the 
potential for biased inferences if naïve techniques are applied have led to considerable 
recent interest in so-called joint models, where models for the event time distribution and 
longitudinal data are taken to depend on some shared latent random effect. A desirable 
feature for joint modeling is that in the absence of the presumed association between the 
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longitudinal data and event times, the analysis should cover the same results as would be 
obtained from separate analyses for each component. 
Most previous work has been based on specific applications. Hogan and Laird (1997ab) 
give an excellent review of models and methods for joint analysis of data of this type. A 
well-known application is in AIDS research in which a biomarker such as CD4 
lymphocyte count is determined intermittently and its relationship with time to 
seroconversion or death is of interest (Pawitan and Self, 1993; Tsiatis et al., 1995; 
Wulfsohn and Tsiatis, 1997). Follman and Wu (1995) develop a class of random effects 
dependent selection models in the more general setting of the shared parameter models, 
which can also account for missing observations. The approach uses generalized linear 
models 
ߞ௒ሺܧሾ ௜ܻ|ܾ௜ሿሻ ൌ ௜ܺߚ ൅ ௜ܹܾ௜ 
ߞ஽ሺܧሾܦ௜|ܾ௜ሿሻ ൌ ܼ௜߶ଵ ൅ ߶ଶܾ௜ 
where ܾ௜ represents the shared random effect for the ݅th subject, ߞ௒ and ߞ஽ are monotone 
link functions, ௜ܺ, ܼ௜ and ௜ܹ are fixed covariate matrices, and ߚ, ߶ଵ, and ߶ଶ are the 
parameters associated with ௜ܺ, ܼ௜ and ܾ௜, respectively. The joint distribution of ௜ܻ and ܦ௜ 
݂ሺݕ௜, ݀௜ሻ ൌ න ݂
௕೔
ሺݕ௜|ܾ௜ሻ݂ሺ݀௜|ܾ௜ሻ݀ܨሺܾ௜ሻ 
is said to follow the shared random parameter model. Likelihood-based estimation 
procedures can accommodate right-censored values of ܦ௜. The likelihood function for a 
random effects model with censored ܦ௜ is 
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ܮ൫߰஽|௒, ߰௒൯ ൌ ෑ න ݂ሺݕ௜|ܾ௜; ߚ, ߪଶሻ݂ሺܾ௜; Γሻ݂ሺ݀ప෩ , ߬௜|ܾ௜; ߰஽|௒ሻܾ݀௜
ே
௜ୀଵ
 
where 
݂൫݀ప෩ , ߬௜หܾ௜; ߰஽|௒൯ ൌ ൣ ஽݂|௕൫݀ప෩ หܾ௜; ߰஽|௒൯൧
ఛ೔ൣ1 െ ܨ஽|௕൫݀ప෩ หܾ௜; ߰௒൯൧
ଵିఛ೔. 
Xu and Zeger (2001) use a latent variable model to describe the relationship between 
time-to-event data, longitudinal response, and covariates, in which covariates could only 
affect the response through its influence on an assumed latent process. The model below 
shows the relationship between event time ܶ, biomarker response ܻ, and treatment 
indicator variable ܺ, by assuming an underlying latent process ߟ corresponding to ܻ.  
ሾܶ, ܻ|ܺሿ ൌ නሾܶ, ܻ|ߟ, ܺሿሾߟ|ܺሿ݀ߟ ൌ නሾܶ|ߟ, ܺሿሾܻ|ߟሿሾߟ|ܺሿ݀ߟ 
The model is established on the basis of three major assumptions 
(a) ܶ and ܻ are conditionally independent given ߟ 
(b) ܺ can affect ܶ either through ߟ or directly 
(c) ܺ only affects ܻ through its influence on ߟ 
To be more specific, ௜ܻሺݐሻ, the observed value of the process at time ݐ is modeled as an 
independent observation from a generalized linear model (GLM) with linear predictor 
ߟ௜ሺݐሻ. That is 
݃ሾܧሼ ௜ܻሺݐሻ|ߟ௜ሺݐሻሽሿ ൌ ߟ௜ሺݐሻ 
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where ߟ௜ሺݐሻ is generally assumed to follow a Gaussian stochastic process. And the model 
allows different forms of conditional hazard to be specified for ሾܶ|ߟ, ܺሿ. An application 
of this model is when the auxiliary variable ܻ is an imperfect surrogate end point for ܶ. 
Fieuws and Verbeke (2006) propose a pairwise approach to resolve the computational 
complexity of high-dimensional joint random effects models. In such framework, 
estimates for the elements in the parameter space are obtained by maximizing each of the 
likelihoods of the pairwise bivariate models separately, instead of maximizing the 
likelihood of the joint mixed model. 
Elashoff et al. (2007) suggest joint modeling of the repeated measurements and 
competing risk failure time data to allow for more than one distinct failure type in the 
survival endpoint. The joint model belongs to the class of random effects selection 
models, using latent random variables and common covariates that link together the sub-
models.  
Huang et al. (2009) present the remeasurement method to diagnose random effect model 
misspecification of the type that leads to biased inference on joint models. The method is 
derived from the SIMEX method to reveal sensitivity of the target estimator to model 
assumptions on the random effects. The results are illustrated and compared with 
application to data for a primary endpoint and a longitudinal process. 
Other useful references include Faucett and Thomas (1996), Lavalley and Degrutolla 
(1996), Faucett et al. (1998), Finkelstein and Schoenfeld (1999), Kalbfleisch and Prentice 
(2002), and Tsiatis and Davidian (2004), Garrett Fitzmaurice et al. (2009, Chapter 13). 
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A further difficulty for making inference on the longitudinal process is that occurrence of 
the event may induce an informative censoring. It is frequently the case that clinical trials 
and observational studies involve some missing data. The occurrence of the key event is 
censored by some competing risk such as disease-related dropout, which could cause 
non-ignorable missing data. Subjects move away, fail to keep some appointments, or die. 
Adjustment of inferences about longitudinal measurements to allow for possibly 
outcome-dependent dropout has been discussed by Wu and Carroll (1988), Hogan and 
Laird (1997ab), and many other authors. Although the selection models we discussed 
have been widely applied to both longitudinal and survival studies, another class of 
models called mixture models appear to be used primarily for studies involved 
informative dropout. In such cases the mechanisms of the missingness in data need 
carefully examination. Valid inference requires a framework in which underlying 
relationships between the event and longitudinal process are explicitly acknowledged. 
We do not discuss this in detail here. 
Our goal is to develop a flexible methodology for handling the categorical longitudinal 
responses and competing risks time-to-event that characterizes the features of our data – 
the Nun Study data (Snowdon, 1997) for research on dementia. We start with the random 
effects dependent selection model formulation of Follman and Wu (1995), extending and 
adapting it to the Nun Study data. A central feature of our modeling strategy is to 
postulate a shared random effect ߛ௜ for subject ݅, and assume that within each subject the 
two components are conditionally independent given the random effect. 
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1.2 Multi-state Markov transition model 
Progression of chronic diseases is often depicted in terms of distinct pre-clinical and 
clinical phases from normal. The idea of using a multi-state Markov model to model the 
transitions among these states and quantify the effects of changes in risk factors is 
straightforward. In particular, a nonhomogeneous Markov model can be easily applied to 
model the progression of disease with increasing or decreasing risks by time. Kay (1986) 
proposed a stochastic process to analyze biomarkers and disease states data in survival 
studies on cancer. Muenz and Rubinstein (1985) used a Markov chain to model a binary 
sequence of states and extended the basic model to allow time-dependent covariates. 
However, there are many circumstances in which estimation of the transition matrix is 
complicated by the complex relationship among transition probabilities. Craig and Sendi 
(2002) summarized methods to obtain the maximum likelihood estimate of the transition 
matrix for discrete-time Markov chains and used the bootstrap method to construct 
confidence intervals for functions of the transition matrix such as expected survival.  
Based on the transitional modeling (Agresti, 2002), Salazar (2004 and 2007) proposed his 
approach featured in modeling longitudinal categorical responses as a multi-state system 
where series of categorical outcomes are expressed in terms of states. The onset and 
progression of these outcomes are modeled as transitions among the states.  
For presentation purpose, we assume a finite stochastic system that consists of three 
transient states and two competing absorbing states. This corresponds to the five 
progression stages in the study of dementia (Tyas et al., 2007). According to Salazar et 
al. (2007), a multinomial logit parameterization could be applied to link the transition 
probabilities with the fix and random effects.  
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݈݋݃ ൬ ௦ܲ௩
ሺߠ௦௩|ࢄ, ࢽሻ
௦ܲଵሺߠ௦ଵ|ࢄ, ࢽ
൰ ൌ ߙ௩ ൅ ࢄᇱࢼ௩ ൅ ߦ௩௦ ൅ ࢃᇱࢽ,      ݒ ൌ 2,3,4,5 
The model formulation in terms of logit functions allows us to find a closed form 
expression for each transition probability and hence to derive the marginal likelihood 
function based on the conditional distribution of the longitudinal response vector ࢟௜. The 
likelihood function for the ݅th subject of his model is 
ܮ௜ሺࢨ|ࢄሻ ൌ න ܮ௜ሺࢨ|ࢄ, ࢽሻ ൈ ݄ሺࢽሻ݀ࢽ ൎ න ෑ ௬ܲ೔೗షభ,௬೔೗ሺࢨ|ࢄ, ࢽሻ ൈ ݄ሺࢽሻ݀ࢽ
௡೔
௜ୀଵ
 
The overall likelihood function can be obtained by evaluating the product of ܮ௜ሺࢨ|ࢄሻ 
defined by the trajectory of subject ݅. We will discuss Salazar’s modeling approach in 
more detail in the following chapter. Yu et al. (2009) suggested to extend this model to 
account for the possible dependency between the baseline information and the random 
effects, and showed improvement in parameter estimation. 
 
1.3 Parameter estimation 
Assuming the random effect is normally distributed, the resultant marginal likelihood 
needs to be evaluated numerically in order to produce parameter estimates. Salazar et al. 
(2007) compared three commonly used techniques for approximating the type of 
integrations: Laplace approximation (Gao, 2004; Skrondal and Rabe-Hesketh, 2004), 
Gauss-Hermite quadrature technique (Hedeker and Gibbons, 1994; Skrondal and Rabe-
Hesketh, 2004), and importance sampling method (Salazar, 2004). Each of the method is 
tested using different distributional assumptions for the random effect during the 
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simulation study. The Gauss quadrature method is recommended in terms of less bias and 
better confidence interval coverage under all distributional forms of the random effect as 
well as its computational simplicity. 
In numerical analysis, Gauss–Hermite quadrature is an extension of Gaussian quadrature 
method for approximating the value of integrals from െ∞ to ∞ of the kind: 
׬ ݁ି௫
మஶ
ିஶ ݂ሺݔሻ݀ݔ. Like all the other forms of Gaussian quadrature, it solves integrals in a 
numerical way by approximating the integral with summation using a series of optimal 
points and weights. In univariate case, the log likelihood function is written as follows 
 ݈݋݃ܮ ൎ logሼ∑ ݓ௤௤ ݁௕೜
మ
ߢ൫ܾ௤൯ ݄ሺܾ௤ሻሽ 
Here ݓ௤ and ܾ௤ are the corresponding Gaussian weights and abscissas (quadrature 
points), and ݂ሺ·ሻ is the probability density function of the random effects term. In 
multivariate case, the approximation is analogous in the sense that each single quadrature 
point is replaced with a multi-dimensional vector of quadrature points (Hedeker and 
Gibbons, 1994). However, the computation can be heavily intensive since the terms in the 
summation increase exponentially as the dimension of random effects grows. Agresti 
(2002) proposed to use an adaptive version of Gauss-Hermite quadrature that requires 
less optimal points and therefore works more efficiently than the ordinary rule. Laplace’s 
method is also deemed to be useful and computationally efficient to construct asymptotic 
approximations in high dimensional settings.  
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1.4 Motivations 
The research on multi-state Markov transition model is motivated by the nature of the 
longitudinal data from the Nun Study (Snowdon, 1997), and similar information on the 
BRAiNS cohort (Salazar, 2004). Here BRAiNS is an acronym for Biologically Resilient 
Adults in Neurological Studies. Information on the progression of participants at risk for 
disease is available at unequally spaced points over time during which the conditions of 
the sisters are assessed and they may transition forward and backward among certain 
non-absorbing states until diagnosed with the dementia (for instance, Alzheimer’s 
Disease). These transient cognitive states are defined as Intact Cognition, Mild Cognitive 
Impairment, and Global Impairment in previous work (Salazar, 2004; Tyas et al., 2007). 
The criteria to classify a nun in a particular transient cognitive state are given below: 
Intact Cognition: The patient passes all cognitive and Activities of Daily Living tests. 
Mild Cognitive Impairment: The patient passes the Delayed Word Recall, Mini-Mental 
State Exam, and Activities of Daily Living tests but fails one or more of the other three 
cognitive tests (Boston Naming, Verbal Fluency, and Constructional Praxis). 
Global Impairment: The patient passes the Delayed Word Recall but fails the Mini-
Mental State Exam, Activities of Daily Living test, and one or more of the other three 
cognitive tests (Boston Naming, Verbal Fluency, and Constructional Praxis) without 
meeting criteria for dementia. 
The cognitive test battery is part of the Consortium to Establish a Registry for 
Alzheimer’s Disease (CERAD). The general structure of the Nun Study data is presented 
in Table 1.1.  
10 
 
Table 1.1 General structures of the Nun Study Data 
Subject 
Observed 
State Cov 1 … Cov p 
Residual 
Survival Cov 1 … Cov q 
Shared 
Random 
Effect 
1 ݕଵଵ  ݔଵଵଵ … ݔଵ௣ଵ ݐଵ ݖଵଵ   … ݖଵ௤   ߛଵ 
   ڭ ڭ … ڭ   …   
   ݕଵ௡భ  ݔଵଵ௡భ  … ݔଵ௣௡భ   …   
2 ݕଶଵ  ݔଶଵଵ … ݔଶ௣ଵ ݐଶ ݖଶଵ  … ݖଶ௤  ߛଶ 
   ڭ ڭ … ڭ   …   
   ݕଶ௡మ  ݔଶଵ௡మ  … ݔଶ௣௡మ    …   
 ڭ ڭ   ڭ …  ڭ ڭ ڭ  … ڭ  ڭ 
݅ ݕ௜ଵ  ݔ௜ଵଵ … ݔ௜௣ଵ ݐ௜ ݖ௜ଵ  … ݖ௜௤  ߛ௜ 
   ڭ ڭ … ڭ   …   
   ݕ௜௡೔  ݔ௜ଵ௡೔ … ݔ௜௣௡೔   …   
 ڭ ڭ   ڭ …  ڭ ڭ ڭ  … ڭ  ڭ 
݉ ݕ௠ଵ  ݔ௠ଵଵ … ݔ௠௣ଵ ݐ௠ ݖ௠ଵ  … ݖ௠௤  ߛ௠ 
   ڭ ڭ … ڭ   …   
   ݕ௠௡೘  ݔ௠ଵ௡೘ … ݔ௠௣௡೘   …   
 
In most longitudinal studies on progression to disease when the target population is 
elderly subjects, death is one of the competing risks. Our analyses on the Nun Study are 
based on data from the eleven successive examinations, which consists of 672 
participants aged 75+ when enrolled in the study. Among the final analytic sample of 461 
subjects, 74 (16%) survived without dementia, 162 (35%) developed dementia, and 225 
(49%) died before converting to dementia. In order to identify risk factors associated with 
transitions and thus to determine the probability that a nun with given risk factors will 
contract dementia before dying, most authors of earlier literature handle death as a 
competing absorbing state to dementia in the Markov process (Salazar, 2004; Salazar et 
al., 2007). In contrast with Salazar’s model, we propose to model the transition 
probability with a four state Markov chain, same transient states (Intact Cognition, 
M.C.I., and G.I.) but dementia being the only absorbing state. We consider incorporating 
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information on the actual residual survival times from death of the subjects into the 
stochastic system. Such an approach could allow different risk factors for dementia and 
death thus to improve the regression estimation since the model likelihood components 
are built up separately.    
Considerable literature can be found that focuses on constructing extended likelihood 
functions to accommodate missing data that are non-ignorable or informative drop-out 
(Follman and Wu, 1995; Ten Have et al., 1998 and 2000; Gao, 2004; Vonesh et al., 2006; 
Li et al., 2007; Shen and Gao, 2007). A popular approach in this respect is to define the 
shared random effects, given which the two likelihood components the follow-up 
response and the drop-out response are assumed to be conditionally independent (Ten 
Have et al., 1998). Recall the random effects dependent selection model formulation of 
Follman and Wu (1995) that we discussed in Section 1.1, the joint distribution of the 
follow-up response ௜ܻ and the censored event time ܦ௜ for the ݅th subject can be expressed 
as 
݂ሺݕ௜, ݀௜ሻ ൌ න ݂
௕೔
ሺݕ௜|ܾ௜ሻ݂ሺ݀௜|ܾ௜ሻ݀ܨሺܾ௜ሻ 
Here the random effects  ܾ௜’s are assumed to have some prior distribution function form 
of ܨሺ·ሻ. This approach was adopted by Yu et al. (2009) for the purpose of extending the 
model likelihood to account for the baseline information. Similarly, we could base the 
analyses on this model formulation which makes it possible for us to incorporate the 
residual survival time of the subjects.  
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One major assumption we made about the residual survival is that the distribution follows 
a parametric family, Weibull in particular. This raises questions on the validity of 
inference in the case when the assumption gets violated. It is of interest to investigate in 
detail how the distributional assumption of the survival would actually affect the 
parameter estimates in the Markov chain. As a preliminary look at the model assumption, 
we can compute the estimated cumulative survival curves by Kaplan-Meier estimation 
method and check the fit statistics. We present a simulation study to further explore the 
impact of distributional assumption of the survival being violated in terms of estimating 
bias and MSE. What if the survival times of the subjects come from other common 
survival distributions, for instance, Log-normal. The influence brought by different 
sample sizes will also be discussed.  
The absorption statistics are of particular interest in a multi-state Markov model. 
Consider an arbitrary finite nonstationary absorbing Markov chain with state space 
ࢁ ൌ ሼ1,2, … , ݑሽ. Define ࢀ to be the set of transient states and ࡾ ൌ ࢀ௖ the set of absorbing 
states. Let ࡼሺ௠,௠ା௞ሻ denote the k-step transition matrix with ݉ being the initial starting 
time of the chain, and ࡼሺ௠,௠ା௞ሻ ൌ ࡼሺ௠,௠ାଵሻ ൈ … ൈ ࡼሺ௠ା௞ିଵ,௠ା௞ሻ, the product of k one-
step transition matrices. In the homogeneous cases, the stationary condition holds we end 
up having ࡼሺ௠,௠ା௞ሻ ൌ ࡼ௞. If there are ݎ absorbing states and ݐ transient states (so in our 
case ݎ=1 and ݐ=3), the one-step transition matrix will have the following canonical form 
ࡼሺଵሻ ൌ ൤
ࡽ௧ൈ௧ ࡾ௧ൈ௥
૙௥ൈ௧ ࡵ௥ൈ௥
൨ 
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For a homogeneous Markov chain, the fundamental matrix ࡹ ൌ ሺࡵ െ ࡽሻିଵ is well-
defined and its elements can be calculated from the converging series ࡹ ൌ ࡵ ൅ ࡽ ൅ ࡽଶ ൅
ڮ.  
However, in situations where the model involves time dependent risk factors such as age, 
the transition probabilities among states vary with time and the underlying transition 
probability matrix is no longer homogeneous. The corresponding fundamental matrix of 
the chain is replaced with an infinite matrix series whose convergence status requires a 
closer examination before the absorption statistics can be properly calculated; while the 
survival component confounding in the chain complicates the problem regarding 
formulation and computation for both the point and interval estimates. 
 
1.5 Outline of the dissertation 
The remainder of this dissertation is organized as follows: 
In Chapter two we proposed our approach to the problem that incorporate a residual 
survival from death to Salazar’s multi-state Markov model (2007). To do so, we treat the 
survival from death as a continuous variable rather than defining death as a competing 
absorbing state to dementia. We assume that within each subject the survival component 
and the Markov process are linked by a shared latent random effect, and moreover, these 
two pieces are conditionally independent given the random effect and their corresponding 
predictor variables. Then a closed-form expression for the individual and thus overall 
conditional marginal likelihood function is derived, which we can evaluate numerically to 
produce the maximum likelihood estimates for the unknown parameters. Later in the 
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chapter we present the results of the simulation studies that design to show how the 
model’s ability to accurately estimate the parameters can be affected by the distributional 
form of the survival term. Finally, we illustrate the results with an application to the Nun 
Study data. We discuss our findings and further provide the results by adding the missing 
portion of the baseline responses previously suggested by Yu et al. (2009) as comparison. 
In Chapter three we consider an extended nonhomogeneous Markov transition model. We 
focus on addressing the problem by accommodating the residual life time of the subjects 
confounding in the nonhomogeneous chain. The convergence status of the chain is 
examined and the formulation of the absorption statistics (1) probability of developing 
dementia before death ݌, and (2) relative risk of absorption between the two competing 
events dementia and death ܴܴ ൌ ௣
ଵି௣
, are derived.  Then we propose using the Delta 
method to estimate the variance terms to construct confidence intervals for ݌ and the 
odds ratio ܱܴ ൌ ቀ ௣భ
ଵି௣భ
ቁ / ቀ ௣మ
ଵି௣మ
ቁ. Since the technique is based on the assumption of the 
asymptotic normal sampling distribution, we carefully check for normality with 
simulated samples (set to have 10,000 iterations). The results are illustrated with the Nun 
study data in detail.  
Finally in Chapter four we summarize the most relevant findings, state the advantages 
and disadvantages of our methodology, and provide the areas for future research.  
 
 
Copyright © Liou Xu 2010   
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Chapter 2 : A Markov transition model with death as a competing event 
 
2.1 Introduction 
In clinical trials and observational studies, it is common that the occurrence of the key 
event is censored by some competing risk such as disease-related dropout, which could 
cause non-ignorable missing data. More specifically, in most longitudinal studies on 
progression to a certain disease when the target population is elderly subjects, death is 
one of the competing risks. In Nun study among the total of 461 subjects – the final 
analytic sample for parameter estimating, almost half (݊ ൌ 225) died before converting 
to dementia. Several existing approaches have been developed in joint analysis of the 
longitudinal measurements and competing risks time-to-event data (Elashoff 2007; Xu 
and Zeger 2001). However, few involve categorical responses that characterize our data.  
Salazar (2007) proposed a suitable approach to the problem by defining a multi-state 
Markov chain to model the progression of dementia in which death was treated as a 
competing absorbing state to dementia. A possible alternative is to model the survival 
from death as continuous variable. We consider incorporating a Weibull survival to 
Salazar’s Markov model assuming a shared random effect. A closed-form expression for 
the conditional marginal likelihood function is derived. The model stability to the 
violation of the assumption on distributional form of survival is tested in simulation 
studies. 
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The chapter is organized as follows: in Section 2.2 we construct the model likelihood 
function; in Section 2.3 we present the results of the simulation studies; in Section 2.4 we 
apply the model to the Nun study data; and in Section 2.5 we summarize our findings.  
 
2.2 Model and estimation 
2.2.1 Salazar’s multi-state Markov model 
Suppose there are ݉ subjects in the study. For subject ݅ let ࢅ௜ ൌ ሺ ௜ܻଵ, … , ௜ܻ௡೔ሻ denote the 
random vector representing the observed cognitive states for subject ݅ at ݊௜ different 
ordered discrete occasions, where ݅ ൌ  1, 2, … , ݉. We assume the Markov property 
holds, that is, the conditional distribution of ݂ ሺݕ௜௞|ݕ௜ଵ, … , ݕ௜௞ିଵሻ is identical to the 
conditional distribution of ݂ ሺݕ௜௞|ݕ௜௞ିଵሻ  for ݇ ൌ  1, 2, … , ݊௜. Then conditioned on ௜ܻଵ, 
the joint distribution of the random vector ࢅ௜ can be written as 
݂ ሺ࢟࢏|ݕ௜ଵሻ  ൌ  ݂ ሺݕ௜ଶ, ݕ௜ଷ, … , ݕ௜௡೔|ݕ௜ଵሻ  ൌ  ݂ ሺݕ௜ଶ|ݕ௜ଵሻ ݂ ሺݕ௜ଷ|ݕ௜ଶሻ …  ݂ ሺݕ௜௡೔|ݕ௜௡೔షభሻ 
Here the subscript ݕ௜௞  refers to the state occupied by the ݅th subject at ݇th occasion. In 
order to simplify the notation, we can use ௬ܲ೔ೖ,௬೔ೖషభ ൌ ݂ ሺݕ௜௞|ݕ௜௞ିଵሻ to denote the one 
step transition probability from state ݕ௜௞ିଵ to state ݕ௜௞. So for instance, if ݕ௜௞ିଵ ൌ ݏ and 
ݕ௜௞ ൌ ݒ, then ௦ܲ௩ represents the probability of transition for subject ݅ from state ݏ to state 
ݒ during the ݇ െ 1th and ݇th visits. Throughout, we use upper-case letters to represent 
random variables and lower-case letters for their realizations; dependence on covariates is 
usually suppressed for notational clarity. 
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In the example to be discussed later – the nun study data, the status of a participant at 
each visit was recorded as being one of the states: intact cognition, mild cognitive 
impairments (M.C.I.), global impairments (G.I.), or dementia (Tyas et. al., 2007). The 
participants were followed during the study period until death occurred. The conditional 
distribution of the status of an individual participant at an arbitrary examination given her 
status at previous examinations was assumed to have the Markov property, i.e., that status 
at the examination depended on only the most recent previous examination and was 
independent of status at other previous examinations. Following Salazar et. al. (2007), a 
multi-state Markov chain was used to model transitions from one state to another, in 
which intact cognition, mild cognitive impairments, and global impairments were 
considered transient states, whereas dementia and death were absorbing states as shown 
in Figure 2.1. 
 
 
Figure 2.1 Possible cognitive transitions between three transient states (1) intact cognition 
(2) M.C.I. (3) G.I. and two absorbing states (4) dementia (5) death 
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Thus the one-step transition probability matrix could be presented in the form of 
ۏ
ێ
ێ
ێ
ۍ ଵܲଵ
ሺࢨ|ࢄ, ࢽሻ ଵܲଶሺࢨ|ࢄ, ࢽሻ ଵܲଷሺࢨ|ࢄ, ࢽሻ
ଶܲଵሺࢨ|ࢄ, ࢽሻ ଶܲଶሺࢨ|ࢄ, ࢽሻ ଶܲଷሺࢨ|ࢄ, ࢽሻ
ଷܲଵሺࢨ|ࢄ, ࢽሻ ଷܲଶሺࢨ|ࢄ, ࢽሻ ଷܲଷሺࢨ|ࢄ, ࢽሻ
ଵܲସሺࢨ|ࢄ, ࢽሻ ଵܲହሺࢨ|ࢄ, ࢽሻ
ଶܲସሺࢨ|ࢄ, ࢽሻ ଶܲହሺࢨ|ࢄ, ࢽሻ
ଷܲସሺࢨ|ࢄ, ࢽሻ ଷܲହሺࢨ|ࢄ, ࢽሻ
0                    0                    0
0                    0                    0
1                    0
0                   1 ے
ۑ
ۑ
ۑ
ې
 
According to Salazar et. al. (2007), a multinomial logit parameterization could be applied 
to link these transition probabilities with the fixed and random effects. 
log ቆ ௦ܲ௩
ሺࣂ௦௩|ࢄ, ࢽሻ
௦ܲଵሺࣂ௦ଵ|ࢄ, ࢽሻ
ቇ ൌ ࢻ௩ ൅ ࢄᇱࢼ௩ ൅ ࣈ௩௦ ൅ ࢃᇱࢽ,   ݒ ൌ 2,3,4,5. 
Here ࢨ represents the set of all the unknown parameters, ࢻ is the vector of intercepts, ࢼ 
is the vector of unknown fixed effects for covariates ࢄ, and ࣈ is the set of unknown fixed 
effects for the prior state. Also, ࢽ is the vector of unobserved random effects associated 
with subject ݅. The formulation of Salazar’s model in terms of logit functions allows us to 
find the closed expression for each transition probability as follows 
௦ܲ௩ሺࢨ|ࢄ, ࢽሻ ൌ
ە
ۖ
۔
ۖ
ۓ 1
1 ൅ ∑ exp ሺࢻ௛ ൅ ࢄᇱࢼ௛ ൅ ࣈ௛
௦ ൅ ࢃᇱࢽሻସ௛ୀଶ
              ݂݋ݎ ݒ ൌ 1
exp ሺࢻ௩ ൅ ࢄᇱࢼ௩ ൅ ࣈ௩௦ ൅ ࢃᇱࢽሻ
1 ൅ ∑ exp ሺࢻ௛ ൅ ࢄᇱࢼ௛ ൅ ࣈ௛
௦ ൅ ࢃᇱࢽሻସ௛ୀଶ
              ݂݋ݎ ݒ ൐ 1
 
Therefore, based on the conditional distribution of ݂ ሺݕ௜ଶ, ݕ௜ଷ, … , ݕ௜௡೔ | ݕ௜ଵሻ the marginal 
likelihood function for the ݅th subject is  
ܮ௜ሺࢨ|ࢄሻ ൌ න ෑൈ ෑ ൫ ௦ܲ௩ሺࢨ|ࢄ, ࢽሻ൯
ఋ೤೔೗షభ,ೞఋ೤೔೗,ೡ݄ሺࢽሻ݀ࢽ                        ሺ2.1ሻ
௦ୀଵڮଷ,
௩ୀଵڮହ
௡೔
௟ୀଶΩ
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with Ω denoting the support for the distribution of the random vector ࢽ. The probability 
density function for ࢽ is ݄ሺ·ሻ. Here ߜ௬೔೗షభ,௦ and ߜ௬೔೗,௩ are indicator functions valued at 1 if 
ݕ௜௟ିଵ ൌ ݏ and ݕ௜௟ ൌ ݒ, and 0 otherwise. The overall likelihood function can be obtained 
by evaluating the product of (2.1) across the subjects under study. However, this 
approach may lead to biased or inconsistent estimates since the likelihood is based on the 
conditional distribution instead of the full distribution in which the baseline information 
is ignored. 
 
2.2.2 Model improvement with Weibull survival 
In Salazar’s model death is modeled as the competing absorbing state to dementia. A 
possible alternative approach is to incorporate information on the actual survival times 
from death of the subjects into the stochastic system.  
Xu and Zeger (2001) proposed a latent variable model to model the relationship between 
time-to-event data, longitudinal response, and covariates, in which covariates could only 
affect the longitudinal response through its influence on an assumed latent process. 
Elashoff et. al. (2006) suggested joint modeling of the repeated measures and competing 
risk failure time data by using latent random variables and common covariates to link the 
sub-models.  
However, in our case the data involves multinomial responses and the parameterization 
of a polychotomous logit under a discrete time Markov framework complicates the 
problem. We hypothesize that the survival times of the subjects come from certain 
parametric distribution which shares the same random effects used in Markov transition 
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model. Additionally these two pieces are conditionally independent given the random 
effects and their corresponding predictor variables. 
In contrast with Salazar’s model, we are modeling the transition probability with a four 
state Markov chain, same transient states but dementia being the only absorbing state. 
The one-step transition probability matrix now becomes 
൦
ଵܲଵሺࢨ|ࢄ, ࢽሻ ଵܲଶሺࢨ|ࢄ, ࢽሻ ଵܲଷሺࢨ|ࢄ, ࢽሻ
ଶܲଵሺࢨ|ࢄ, ࢽሻ ଶܲଶሺࢨ|ࢄ, ࢽሻ ଶܲଷሺࢨ|ࢄ, ࢽሻ
ଷܲଵሺࢨ|ࢄ, ࢽሻ ଷܲଶሺࢨ|ࢄ, ࢽሻ ଷܲଷሺࢨ|ࢄ, ࢽሻ
ଵܲସሺࢨ|ࢄ, ࢽሻ
ଶܲସሺࢨ|ࢄ, ࢽሻ
ଷܲସሺࢨ|ࢄ, ࢽሻ
      0                    0                    0        1
൪ 
Each transition probability ௦ܲ௩ could be postulated in the form of  
௦ܲ௩ሺࢨ|ࢄ, ࢽሻ ൌ
ە
ۖ
۔
ۖ
ۓ 1
1 ൅ ∑ exp ሺࢻ௛ ൅ ࢄᇱࢼ௛ ൅ ࣈ௛
௦ ൅ ࢃᇱࢽሻସ௛ୀଶ
              ݂݋ݎ ݒ ൌ 1
exp ሺࢻ௩ ൅ ࢄᇱࢼ௩ ൅ ࣈ௩௦ ൅ ࢃᇱࢽሻ
1 ൅ ∑ exp ሺࢻ௛ ൅ ࢄᇱࢼ௛ ൅ ࣈ௛
௦ ൅ ࢃᇱࢽሻସ௛ୀଶ
              ݂݋ݎ ݒ ൐ 1
 
We further assume the survival time ࡿ ~ ܹܾ݁݅ݑ݈݈ሺݎ ൐ 0, ࣆሻ, where ࣆ ൌ ݁ఎబାࢆᇲࣁାࢃᇲࢽ. 
The probability of the ݅th subject failing from the competing risk of death is 
ߨሺ ௜ܵ ൌ ݐ௜|ࢨ, ࢽሻ ൌ ൣݎ݁ఎబାࣁ
ᇲ௓೔ା࢝೔ᇲఊ೔ݐ௜
௥ିଵ݁ݔ݌൫െ݁ఎబାࣁ
ᇲ௓೔ା࢝೔ᇲఊ೔ݐ௜
௥൯൧
ఛ೔
ൣ݁ݔ݌൫െ݁ఎబାࣁ
ᇲ௓೔ା࢝೔ᇲఊ೔ݐ௜
௥൯൧
ଵିఛ೔ 
Here ߬௜ is some indicator function valued at 1 if the ݅th subject died at time ݐ௜ and 0 
otherwise. ࢨ is the parameter vector associated with both the transition probability and 
the probability of death. For each subject under study, the conditional marginal likelihood 
function for the ݅th subject can be rewritten as 
ܮ௜ሺࢨ|ࢄ, ࢆሻ ൌ න ෑൈ ෑ ൫ ௦ܲ௩ሺࢨ|ࢄ, ࢽሻ൯
ఋ೤೔೗షభ,ೞఋ೤೔೗,ೡ ൈ ߨௌ೔ሺࢨ|ࢆ, ࢽሻ݄ሺࢽሻ݀ࢽ
௦ୀଵڮଷ,
௩ୀଵڮସ
௡೔
௟ୀଶ
. 
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2.2.3 Parameter estimation 
Assuming that the random effect is distributed as a ܰሺ0, ߪଶሻ, the resultant log likelihood 
can be maximized using the Gauss-Hermite quadrature method combined with the 
Newton-Raphson method to numerically evaluate the derivatives and produce the 
parameter estimates. The estimates of the standard errors are computed by Fisher’s 
information method.  
 
2.3 Simulations 
The main purpose of the simulation study is to examine the sensitivity of the MLEs to the 
violations of the Weibull model assumption on the survival time. We want to quantify 
how the distributional form for the survival term affects the model estimates associated 
with the fixed effects. In addition, the model’s ability to accurately estimate the unknown 
parameters is of interest. To answer these questions we look at two aspects: (i) the bias of 
the MLEs to the true parameters and (ii) the mean squared errors of the MLEs.  
The simulation was set to have 300 iterations, with each containing 200 or 500 subjects. 
Each subject has up to ten follow-up waves starting from a baseline state of intact 
cognition. We considered four cases: 
1. Total of 200 subjects generated with prior distribution of survival being Weibull 
2. Total of 500 subjects generated with prior distribution of survival being Weibull 
3. Total of 200 subjects generated with prior distribution of survival being Lognormal  
4. Total of 500 subjects generated with prior distribution of survival being Lognormal 
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In the cases when the true prior distribution of survival being lognormal (case 3 and 4), 
the probability density functions were plotted along with the simulated Weibull 
distribution for comparison. As shown in Figure 2.2, the red line representing the 
lognormal densities from which the survival times of the simulation populations in case 3 
and 4 were generated; and the blue line indicating the simulated Weibull distribution that 
we fit in our model. The four plots correspond with the four possible combinations of the 
values from the two model covariates. The relative location and diversity of the two 
curves differ by the values of the covariates. 
Thus two sets of comparison could be made to explore: first, the effects of varying the 
sample size, and second, the effects of violating the original model assumption on the 
distributional form of survival term with a possible alternative.  
In both situations, the transition probabilities were dependent on three covariates age, 
prior state (intact cognition or M.C.I. or G.I.), and the presence/absence of an 
apolipoprotein E-4 allele (APOE4). The covariates entered in the survival model were 
age at entry and the APOE4 status of the subject. All the simulations were done using the 
IML procedure in SAS system. The results are presented in Table 2.1. 
  
23 
 
Figure 2.2 Probability densities of the prior distribution of survival (True vs. Simulated) 
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Table 2.1 Bias and Mean squared error of the model parameters 
(Base state: 1 = Intact Cognition)  
Risk Factors State 
True 
Parameter 
Weibull survival  
(200 subjects) 
Weibull survival  
(500 subjects) 
      Bias MSE Bias MSE 
Age 2 0.07  -0.0035 0.00046  -0.0017 0.00024  
  3 0.19  0.0039  0.00097 0.0025  0.00040 
  4 0.21  0.0713  0.01030 0.0593  0.00520 
APOE4 2 0.27  -0.0854 0.07311  -0.0636  0.03143 
  3 0.39  -0.1208  0.14037 -0.1092  0.04940 
  4 1.62  0.0221  0.35017 -0.0065  0.09960 
Prior state:             
    Intact Cognition 2 0.58  0.1389  0.30218 0.0884  0.08680 
  3 -3.12  0.0547  0.09054 0.0142  0.03484 
  4 -4.15  -0.2528  0.55932 -0.1517  0.21298 
     Mild Cognitive 2 1.79  0.1139  0.30504 0.0683  0.08110 
         Impairment 3 -2.43  0.0142  0.11078 0.0033  0.04011 
  4 -2.26  -0.1115  0.40921 -0.0953  0.14037 
        
Risk Factors State 
True 
Parameter 
Lognormal survival  
(200 subjects) 
Lognormal survival  
(500 subjects) 
      Bias MSE Bias MSE 
Age 2 0.07 0.0185  0.00070 0.0226  0.00064 
  3 0.19 0.0259  0.00150 0.0334  0.00147 
  4 0.21 0.0997  0.01372 0.0939  0.01032 
APOE4 2 0.27 -0.2442  0.10083 -0.1760  0.04622 
  3 0.39 -0.2733  0.16793 -0.2665  0.09779 
  4 1.62 -0.0983  0.20157 -0.1794  0.10875 
Prior state:             
Intact Cognition 2 0.58 -0.2302  0.27467 -0.2802  0.14252 
  3 -3.12 -0.2799  0.16309 -0.2801  0.11369 
  4 -4.15 -0.9934  0.75993 -0.4577  0.82227 
     Mild Cognitive 2 1.79 0.0222  0.20501 0.0036  0.06647 
         Impairment 3 -2.43 -0.0134  0.08151 0.0208  0.03255 
  4 -2.26 -0.0513  0.22739 -0.0255  0.09625 
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In general, increasing the sample size would improve the estimates in terms of reducing 
bias and MSE when the Weibull is the true distribution as we assumed. In the case when 
the prior distribution of survival being lognormal instead, only MSE was influenced by 
increasing the sample size from 200 to 500, while bias did not change much. Moreover, 
the results indicate that the maximum likelihood estimates are not sensitive to violations 
of the assumed Weibull model in the case when the lognormal is the true distribution. 
 
2.4 Application to the Nun Study 
The Nun Study began enrollment in 1991. The data consists of a cohort of 672 members 
of the School Sisters of Notre Dame born before 1917 and living in retirement 
communities in the Midwestern, eastern, and southern United States. The subjects were 
recruited in phases and received periodic cognitive assessments with brain donation at 
death. Analyses were based on data from the eleven successive examinations. A total of 
211 subjects were excluded from the study due to: missing examinations, missing APOE 
data, or presence of dementia at baseline visit. The final analytic sample consisted of 461 
participants, of which 74 survived without dementia, 162 developed dementia, and 225 
died before converting to dementia. The transitions among the cognitive states are 
summarized in Table 2.2 below. 
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Table 2.2 Number of transitions in the Nun Study 
  Current Visit 
Prior Visit Intact Cognition M.C.I. G.I. Dementia 
Intact Cognition 593 (69.9%) 
197 
(23.2%) 
54       
(6.3%) 
5         
(0.6%) 
M.C.I. 177   (16.2%) 
697   
(63.8%) 
136   
(12.5%) 
82       
(7.5%) 
G.I. 16       (5.1%) 
39     
(12.4%) 
184   
(58.6%) 
75    
(23.9%) 
Dementia 0           (0%) 
0           
(0%) 
0           
(0%) 
81      
(100%) 
 
The covariates of interest were age, education level, APOE4 status, and prior state. For 
simplicity purposes education was not included in the model in our simulations; but was 
considered here since it is a well-known risk factor and found to be significantly 
associated with dementia in previous studies. The covariates entered in the survival 
model were age at entry and APOE4 status. As shown in Figure 2.3 below, subjects were 
subgrouped based on their APOE4 status and age at entry, and thus four Weibull 
probability plots were created as a preliminary look at the model assumption. The 
estimated cumulative distribution function was computed by Kaplan-Meier estimation in 
the Lifereg procedure in SAS. The straight line represents the maximum likelihood fit, 
with the simultaneous parametric confidence bands on each side. The values of the 
censored observations are plotted along the top of each graph in red. The plots indicate 
that the assumed Weibull model fits the data reasonably well although not perfect since 
skewness arises in the tail of the distribution for some of the groups. 
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Figure 2.3 Weibull probability plots of the survival time in the Nun Study 
  
 
 
Similarly assuming the survival time of the subjects follows a lognormal distribution, the 
data was fitted and tested with the same covariates. It suggests that Weibull model is a 
better fit to the data. The lognormal probability plots for the four subgroups are illustrated 
in Figure 2.4. 
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Figure 2.4 Lognormal probability plots of the survival time in the Nun Study 
 
 
 
Table 2.3 lists the parameter estimates for the transition probabilities. First, as expected 
Age and APOE4 are significant predictors of a transition to M.C.I., G.I., and Dementia as 
opposed to a transition to cognitively normal because all the coefficients associated with 
Age and APOE4 are significant. The odds ratios ORAge=(1.10, 1.19, 1.18) and 
ORAPOE4=(2.31, 3.64, 4.10) are significantly different from one. Second, remaining 
cognitively intact favors the highly educated. Compared to those with more than 16 years 
of education, subjects with 12 years or less have significant odds ratios for transitions to 
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M.C.I. (OR=4.55) and G.I. (OR=4.77); Similarly, the corresponding odds ratios to M.C.I. 
(OR=1.59) and G.I. (OR=1.64) are significant for those with exactly 16 years of 
education. These results are consistent with those from previous studies. Moreover, Age 
and APOE4 are both significant predictors for survival time but education is not. The 
coefficient associated with Age is negative indicating that an elderly age at entry could be 
“protective” for subjects from the competing risk of death. That is, the likelihood of 
dementia before death increases with age. 
Table 2.3 Maximum likelihood estimates (SE) of model parameters in the Nun Study 
(Base state: 1 = Intact Cognition)  
Risk Factors State Estimates
Std. 
Error Risk Factors State Estimates
Std. 
Error 
Markov chain       Prior states:       
Age 2 0.092* (0.016) Intact Cognition 2 -1.232* (0.334) 
  3 0.172* (0.020)   3 -3.834* (0.326) 
  4 0.169* (0.023)   4 -5.344* (0.545) 
APOE4 2 0.838* (0.232) Mild Cognitive 2 0.670* (0.327) 
  3 1.292* (0.263)        Impairment 3 -2.375* (0.306) 
  4 1.412* (0.297)   4 -1.997* (0.327) 
Education:       Weibull  survival       
     < 16 years 2 1.515* (0.348) Age at Entry - -1.523* (0.183) 
    vs. > 16 years 3 1.562* (0.391) APOE4 - 0.447* (0.220) 
  4 1.403* (0.436) Rate  - 4.613* (0.272) 
     16 years  2 0.465* (0.158)         
    vs. > 16 years 3 0.497* (0.194) Sigma - 0.871* (0.100) 
  4 0.372 (0.235)         
 
* Significant at P < 0.05 
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2.5 Conclusion and discussion 
Considerable literature has focused on characterizing the relationship between 
longitudinal response process and time-to-event data. In contrast, relatively little research 
has been done to accommodate multinomial responses, with even fewer relying on a 
polychotomous logit parameterization under a discrete-time Markov chain. 
As an improvement to Salazar’s multi-state Markov model, we fit a Weibull model to the 
survival from death and correlate it with the Markov transition model by defining a 
shared random effect. The simulation study showed model stability in terms of violations 
of the distributional assumption on survival time. More specifically, the maximum 
likelihood estimates are not sensitive to violations of the assumed Weibull model if, in 
fact, a lognormal model should be used instead.  
The application to the Nun study data found that Age and APOE4 are significant 
predictors of a transition to impaired states and Dementia as opposed to a transition to 
cognitively normal because all the coefficients associated with Age and APOE4 are 
significant and positive. Remaining cognitively intact favors the highly educated (> 16 
years education) which also agrees with the results from the previous models. Age and 
APOE4 are both significant predictors for survival time. Age at entry is “protective” for 
subjects from the competing risk of death since older subjects are more likely to become 
demented before death.  
Yu et. al. (2009) incorporated the missing portion of the baseline likelihood into the 
follow-up likelihood by assuming the two share the same random effect. The complete 
marginal likelihood function for the ith subject with baseline can be written as  
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ܮ௜ሺࢨ, ࢶ|ࢄሻ ൌ න ෑൈ ෑ ൫ ௦ܲ௩ሺࢨ|ࢄ, ࢽሻ൯
ఋ೤೔೗షభ,ೞఋ೤೔೗,ೡ ൈ ߨ௬೔భሺࢶ|ࢄ஻, ࢽሻ݄ሺࢽሻ݀ࢽ
௦ୀଵڮଷ,
௩ୀଵڮହ
௡೔
௟ୀଶ
 
Here ࢶ is the set of parameters associated with the baseline response components. The 
probability of the baseline state ߨ௬೔భሺࢶ|ࢄ஻, ࢽሻ was similarly modeled by using 
multinomial logistic regression as for the one-step transition probability ௦ܲ௩ሺࢨ|ࢄ, ࢽሻ in 
the follow-up likelihood. It will also be interesting to combine this approach with our 
model to find a complete likelihood function that accommodates all the three pieces 
baseline, follow-up, and survival.  
The results from the Nun study data are presented in Table 2.4 below. Note that in this 
application 81 subjects who were diagnosed with dementia at the baseline visit entered to 
help estimate the baseline effects. Those subjects were dropped from our previous model 
without the baseline likelihood component. 
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Table 2.4 Maximum likelihood estimates (SE) of model parameters with baseline 
Risk Factors State Estimates
Std. 
Error Risk Factors State Estimates
Std. 
Error 
Markov chain       Baseline       
Age 2 0.118* (0.017) Age 2 0.121* (0.034) 
  3 0.199* (0.020) 3 0.269* (0.040) 
  4 0.196* (0.023) 4 0.270* (0.037) 
APOE4 2 1.078* (0.263) APOE4 2 0.642 (0.367) 
  3 1.536* (0.291) 3 1.400* (0.447) 
  4 1.649* (0.322)   4 1.703* (0.400) 
Education:       Education:       
     < 16 years 2 1.829* (0.388) < 16 years 2 2.215* (0.623) 
    vs. > 16 years 3 1.873* (0.427) vs. > 16 years 3 2.588* (0.706) 
  4 1.713* (0.468) 4 3.247* (0.653) 
     16 years  2 0.590* (0.177) 16 years 2 0.660* (0.287) 
    vs. > 16 years 3 0.618* (0.209) vs. > 16 years 3 0.458 (0.399) 
  4 0.493* (0.247) 4 0.693* (0.352) 
Prior states:       Weibull  survival       
     Intact Cognition 2 -0.837* (0.339) Age at Entry - -1.701* (0.198) 
3 -3.437* (0.330) APOE4 - 0.552* (0.248) 
  4 -4.947* (0.548) Rate  - 5.081* (0.279) 
Mild Cognitive  2 0.701* (0.335)         
Impairment   3 -2.346* (0.314) Sigma - 1.212* (0.085) 
  4 -1.968* (0.335)         
 
* Significant at P < 0.05 
 
We can see that although the new model produced similar values of the parameter 
estimates as our previous model, the magnitude of odds ratios are larger for all the risk 
factors Age, APOE4 status, education level and prior state under the new model with 
baseline. For example, keeping other covariates constant, the odds ratio of having 
APOE4 present for transitions from intact cognition to M.C.I. is 2.31, to G.I. is 3.64 and 
to dementia is 4.10 under the previous model. In comparison, the corresponding odds 
ratios are 2.94, 4.65 and 5.20 under the current model with baseline likelihood 
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component. The results are similar for the other risk factors in the model. The comparison 
of fit statistics presented in Table 2.5 also suggests that the inclusion of the baseline 
component might help make up for those information potentially missing from our 
previous model and improve the parameter estimates. 
Table 2.5 Comparison of fit statistics in the Nun Study data 
Fit  Statistics 
Model wo 
Baseline 
- Weibull 
Model w 
Baseline 
- Weibull 
Model w 
Baseline 
- Lognormal 
-2 Log Likelihood 6855.2 6814.3 7027.9 
AIC 6937.2 6896.3 7109.9 
AICC 6938.7 6897.8 7111.4 
BIC 7113.3 7072.4 7286.0 
 
Future extensions of the model may include considering the random-effects models, in 
which less strict assumptions about the association between the two outcomes ࢅଵ and ࢅଶ 
are required. The general idea is to define separate but correlated latent variables ࢈ଵ and 
࢈ଶ for ࢅଵ and ࢅଶ, and let ݂ሺ࢈ଵ, ࢈ଶሻ denote the joint density (often bivariate normal). 
Then by assuming conditional independence of ࢅଵ and ࢅଶ given ሺ࢈ଵ, ࢈ଶሻ, the joint 
density of ሺࢅଵ, ࢅଶሻ can be obtained from 
݂ሺ࢟ଵ, ࢟ଶሻ ൌ ඵ ݂ሺ ࢟ଵ|࢈ଵሻ݂ሺ࢟ଶ|࢈ଶሻ݂ሺ࢈ଵ, ࢈ଶሻ݀࢈ଵ݀࢈ଶ. 
A more flexible setting is to consider using a proportional hazard model for the residual 
survival time of the subject depending on fixed effects ࢠ௜ and random effect ܾଶ௜ 
݄௜ሺݐ|ܾଶ௜ሻ ൌ ݄଴ሺݐሻ expሺࢠ௜
ᇱߚ ൅ ߙᇱܾଶ௜ሻ 
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with piecewise-constant baseline hazard (step-functions): ݄଴ሺݐሻ ൌ ∑ ߦ௤ܫሺݒ௤ିଵ ൏ ݐ ൑
ொ
௤ୀଵ
ݒ௤ሻ where 0 ൌ ݒ଴ ൏ ݒଵ ൏ ڮ ൏ ݒொ denotes a split of the time scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Liou Xu 2010   
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Chapter 3 : Extended nonhomogeneous Markov transition model 
 
3.1 Introduction 
In the study of chronic diseases like Alzheimer’s, it is commonly the case that the 
investigators are particularly interested in the probability of disease onset before dying 
given a set of risk factors such as age, education, and genetic status. The purpose of this 
chapter is to continue the study for an extended nonhomogeneous Markov transition 
model that involves time dependent risk factors as well as the survival component. In that 
case, the underlying transition probability matrix is no longer stationary. The 
convergence status of the chain needs further examination before the absorption statistics 
can be computed.  
The remainder of the chapter is organized as follows: Section 3.2 introduces notations for 
defining common absorption statistics; investigates the convergence status of the 
fundamental matrix series and derives the formulas to compute the probability of 
dementia before death. Section 3.3 illustrates the use of the Delta method to construct 
confidence intervals for the transition probabilities to dementia and the odds ratios. In 
Section 3.4 the results are applied to the Nun Study. Section 3.5 compares the results 
under a simplified model with the risk indicator variable that combines the effects of the 
original risk factors APOE4 and Education. Conclusions are summarized in Section 3.6. 
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3.2 Nonhomogeneous Markov chain 
3.2.1 Notation and definition 
A homogenous Markov chain has lots of nice properties and attributes. We can argue that 
in the homogeneous case the absorption of transient states is guaranteed and the 
absorption statistics can be calculated explicitly. However, the chain considered here 
involves time dependent risk factors such as age, in which case the transition probabilities 
among states vary with time and thus the underlying transition probability matrix is no 
longer stationary. In this section, we continue to investigate for the convergence status 
and the statistics characterizing transitions and absorptions among states for a 
nonhomogeneous chain. 
Now consider an arbitrary finite absorbing nonstationary Markov chain with state space 
ࢁ ൌ ሼ1,2, … , ݑሽ. Define ࢀ to be the set of transient states and ࡾ ൌ ࢀ௖ the set of absorbing 
states. Let ࡼሺ௠,௠ା௞ሻ denote the k-step transition matrix with ݉ being the initial starting 
time of the chain, and ࡼሺ௠,௠ା௞ሻ ൌ ࡼሺ௠,௠ାଵሻ ൈ … ൈ ࡼሺ௠ା௞ିଵ,௠ା௞ሻ, the product of k one-
step transition matrices. ࡼሺ௠,௠ା௞ሻ can also be expressed in the following canonical form: 
ࡼሺ௠,௠ା௞ሻ ൌ ൤ࡽ
ሺ௠,௠ାଵሻ ࡾሺ௠,௠ାଵሻ
0 ࡵ
൨ ൈ ڮ ൈ ൤ࡽ
ሺ௠ା௞ିଵ,௠ା௞ሻ ࡾሺ௠ା௞ିଵ,௠ା௞ሻ
0 ࡵ
൨ 
                           ൌ ൤∏ ࡽ
ሺ௠ା௟ିଵ,௠ା௟ሻ௞
௟ୀଵ ࡾככ
0 ࡵ
൨ 
here ࡾככ ൌ ࡾሺ௠,௠ାଵሻ ൅ ࡽሺ௠,௠ାଵሻࡾሺ௠ାଵ,௠ାଶሻ ൅ ڮ ൅ ࡽሺ௠,௠ା௞ିଵሻࡾሺ௠ା௞ିଵ,௠ା௞ሻ. ࡽ and ࡾ 
are the substochastic matrices describing transitions among the transient states and 
transitions from the transient states to the absorbing states, respectively. 
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Suppose the chain starts from transient state ݅ at time ݉. Note that when the stationary 
condition holds we have ࡼሺ௠,௠ା௞ሻ ൌ ࡼ௞ since transitions in the chain no longer depend 
on time.  
The following subsections will focus on addressing the problem by accommodating the 
residual survival time of the subject confounding in the nonhomogeneous chain. The 
formulation of the absorption statistics and the construction of their confidence intervals 
are discussed in detail. 
 
3.2.2 Probability of dementia before death 
Suppose that a certain subject has initially started the process from state ݅, ݅ א ࢀ. Let ௡ܻ 
be the state that the process visits at time ݊. Let ܹ ൌ min௡ሺ ௡ܻ ൌ ݆ሻ, ݆ א ࡾ, which is the 
time it takes for the process to enter an absorbing state. ܹ is only observed at each visit 
time. Further define ܵ to be the residual life time of this subject at the time he/she 
enrolled in the study. ܵ is continuous. 
Recall that in the previous chapter we hypothesize that the residual survival times of the 
subjects come from known parametric distribution sharing the same random effects used 
in Markov chain, i.e. here ௌ݂ሺ· |ࢨ, ࢽሻ and ܨௌሺ· |ࢨ, ࢽሻ being the conditional Weibull 
probability density function and cumulative distribution function, respectively. 
Let ݉ denote the initial starting time. For each fixed ݐ, the probability that absorption 
occurs after time ݐ can thus be derived. ׊ ݅ א ࢀ, we have 
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          ܲሺܹ ൑ ݐ|ࢨ, ࢽሻ ൌ ܲሺܹ ൑ ݐכ|ࢨ, ࢽሻ ൌ ∑ ܲሺܹ ൌ ݒ|ࢨ, ࢽሻ௧כ௩ୀଵ    
                                    ൌ ൣࡾሺ௠,௠ାଵሻ ൅ ∑ ൫∏ ࡽሺ௠ା௟ିଵ,௠ା௟ሻ௩௟ୀଵ ൯௧
כିଵ
௩ୀଵ ࡾ
ሺ௠ା௩,௠ାଵା௩ሻ൧ሺ݅ሻ 
                                    ൌ ൣ∑ ࡽሺ௠,௠ା௩ሻ௧כିଵ௩ୀ଴ ࡾሺ௠ା௩,௠ାଵା௩ሻ൧ሺ݅ሻ 
where ݐכ ൌ ہݐۂ ൌ maxሼݔ߳Ժ|ݔ ൑ ݐሽ.  
ܲሺܹ ൌ ݐכ|ࢨ, ࢽሻ ൌ ሾࡽሺ௠,௠ା௧
כିଵሻࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ 
So, ׊ ݅ א ࢀ, 
ܲሺܹ ൏ ܵ|ࢨ, ࢽሻ ൌ ෍ ܲሺܹ ൌ ݐכ, ܵ ൐ ݐכ|ࢨ, ࢽሻ ൌ
ஶ
௧כୀଵ
෍ ܲሺܹ ൌ ݐכ|ࢨ, ࢽሻ
ஶ
௧כୀଵ
ܲሺܵ ൐ ݐכ|ࢨ, ࢽሻ 
     ൌ ෍ ሾࡽሺ௠,௠ା௧
כିଵሻ
ஶ
௧כୀଵ
ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · න ௌ݂ሺݐ|ࢨ, ࢽሻ݀ݐ
ஶ
௧כ
 
       ൌ ෍ ሾࡽሺ௠,௠ା௧
כିଵሻ
ஶ
௧כୀଵ
ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ 
Yu et al. (2009) showed that under certain conditions the norm of the substochastic 
matrix ฮࡽሺ௠,௡ሻฮ converges to zero as ݊ ՜ ∞. Following the property of cumulative 
distribution functions 0 ൑ ܨௌሺݐכ|ࢨ, ࢽሻ ൑ 1, we have  
׊ ݅ א ࢀ, ܲሺܹ ൏ ܵ|ࢨ, ࢽሻ ൑ ෍ ሾࡽሺ௠,௠ା௧
כିଵሻ
ஶ
௧כୀଵ
ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ 
The probabilities of dementia before death converge with time.   
We have                            ܲሺܹ ൐ ܵ|ࢨ, ࢽሻ ൌ 1 െ ܲሺܹ ൏ ܵ|ࢨ, ࢽሻ 
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Therefore, by taking the integral over the whole support for the distribution of the 
random vector ࢽ, we have 
ܲሺܹ ൏ ܵ|ࢨሻ ൌ න ෍ ሾࡽሺ௠,௠ା௧
כିଵሻ
ஶ
௧כୀଵ
ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ݄ሺࢽሻ ݀ࢽ 
where ݄ሺ·ሻ denotes the probability density function for ࢽ. 
Given the random effects, the relative risk of absorption between the two competing 
events can be derived by taking the ratio 
ܴܴ ൌ
ܲሺܹ ൏ ܵ|ࢨሻ
ܲሺܹ ൐ ܵ|ࢨሻ
 
ൌ
׬ ∑ ሾࡽሺ௠,௠ା௧
כିଵሻஶ
௧כୀଵ ࡾ
ሺ௠ା௧כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ ݄ሺࢽሻ݀ࢽ
1 െ ׬ ∑ ሾࡽሺ௠,௠ା௧כିଵሻஶ௧כୀଵ ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ ݄ሺࢽሻ݀ࢽ
 
The resultant integral can be solved numerically using the Gauss-Hermite quadrature 
method as discussed in Section 1.3. 
 
3.3 Construction of confidence intervals 
Our primary research interest in this study is to estimate the confidence intervals 
associated with the probabilities and odds ratios of developing dementia before death. 
One such approach is using the Delta method to estimate the corresponding standard 
errors and construct the confidence intervals based on the assumption of the normal 
sampling distribution.  
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It is necessary for us to check the normality of the estimated ݌ and ܱܴ in the Nun Study 
before applying the method. In the case when the distribution of ݌ (or ܱܴ) is skewed 
from normal, we will also look at possible transformations, such as logarithm of the 
statistic, for a better interval estimate. 
 
3.3.1 Checking for normality 
As shown in the diagram below, the simulation is performed in the following steps: 
Step1. The maximum likelihood estimates ࢼ෡ as well as the associated covariance matrix 
ܿ݋ݒሺࢼ෡ሻ can be derived from our model as discussed in the previous chapter; 
Step2. Each individual vector of ࢼ෩௜ is generated from the multivariate normal distribution 
ܯܸܰሺࢼ෡, ܿ݋ݒ൫ࢼ෡൯ሻ; 
Step3. The transition probability matrices ࡼ෩௜
ሺ௠,௠ା௧ሻሺࢄ|ࢼ෩ሻ and the cumulative survival 
distribution functions ܨௌ൫ݐ|ࢼ෩൯ are then estimated; 
Step4. The probability of developing dementia before death can be calculated from the 
submatrices ࡽ෩௜
ሺ௠,௠ା௧ିଵሻሺࢄ|ࢼ෩ሻ, ࡾ෩௜
ሺ௠ା௧ିଵ,௠ା௧ሻሺࢄ|ࢼ෩ሻ, and ܨௌ൫ݐ|ࢼ෩൯; 
Step5. The ݌௜s and ܱܴ௜s as well as their functional transformations i.e., ܽݎܿݏ݅݊ඥ݌௜ and 
ln ሺܱܴ௜ሻ are computed; 
Step6. Repeat the above steps for n times; 
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Step7. Standard univariate procedures are conducted to evaluate and compare the 
normality of these statistics ݌௜, ܱܴ௜, ܽݎܿݏ݅݊ඥ݌௜, and ln ሺܱܴ௜ሻ. 
Figure 3.1 Diagram of the data generation procedure 
 
 
 
 
 
 
 
 
 
 
 
 
 
For illustration purposes, we pick a typical nun with baseline age 80, apoe4 positive, less 
than 16 years of education, and initial state being intact cognition. (The results for initial 
state being M.C.I. or G.I. are quite similar.) The number of iterations is 10,000.  
We are looking at the sampling distribution of ݌ ൌ Pr ሺ݀݁݉݁݊ݐ݅ܽ ܾ݂݁݋ݎ݁ ݀݁ܽݐ݄ሻ, the odds 
ratio ܱܴ ൌ
೛భ
భష೛భ
೛మ
భష೛మ
 , and the log or other type of transformations of them. To compute the 
odds ratio, ݌ଶ is taken from a nun with same baseline age, education level, and initial 
state, but apoe4 negative. The main output is presented as follows: 
Given True ࢼ
ࢼ෩௜ ~ ܯܸܰሺࢼ෡, ܿ݋ݒ൫ࢼ෡൯ሻ 
ࡼ෩௜
ሺ௠,௠ା௧ሻሺࢄ|ࢼ෩ሻ and ܨௌሺݐ|ࢼ෩ሻ 
ࡽ෩௜
ሺ௠,௠ା௧ିଵሻሺࢄ|ࢼ෩ሻ, ࡾ෩௜
ሺ௠ା௧ିଵ,௠ା௧ሻሺࢄ|ࢼ෩ሻ, 
and ܨௌሺݐ|ࢼ෩ሻ 
݌௜ and ܱܴ௜  
Functional transformations of ݌௜ and ܱܴ௜  
n Iterations
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Figure 3.2 Checking for normality of p in the Nun Study 
 
 
 
       Goodness-of-Fit Tests for Normal Distribution 
 
        Test                  ----Statistic-----   ------p Value------ 
 
                  Kolmogorov-Smirnov    D       0.00791052   Pr > D        0.132 
                  Cramer-von Mises      W-Sq    0.15989975   Pr > W-Sq     0.019 
                  Anderson-Darling      A-Sq    1.16387869   Pr > A-Sq    <0.005 
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Figure 3.3 Checking for normality of OR in the Nun Study 
 
 
 
 
       Goodness-of-Fit Tests for Normal Distribution 
 
        Test                  ----Statistic-----   ------p Value------ 
 
                  Kolmogorov-Smirnov    D       0.00686499   Pr > D       >0.150 
                  Cramer-von Mises      W-Sq    0.12037271   Pr > W-Sq     0.063 
                  Anderson-Darling      A-Sq    0.86690532   Pr > A-Sq     0.026 
 
 
The results suggest that direct estimates of ݌, ln ሺ݌ሻ, ௣
ଵି௣
, and ݈݊ ቀ ௣
ଵି௣
ቁ are not asymptotic 
normal while in comparison ܽݎܿݏ݅݊ඥ݌, the inverse trigonometric function of the square 
root of ݌, is more likely to be normally distributed. Moreover, the sampling distribution 
for ln ሺܱܴሻ is also normal, the hypothesis testing of normality is not rejected. 
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Consequently, based on asymptotic normal assumption, we would thus look at ܽݎܿݏ݅݊ඥ݌ 
and ln ሺܱܴሻ to construct the confidence interval for ݌ and ܱܴ. 
 
3.3.2 Applying the Delta method 
(i) s.e. for arcsin ඥ݌ using Delta method 
Let ݌ ൌ Pr ሺ݀݁ݒ݈݁݋݌݅݊݃ ݀݁݉݁݊ݐ݅ܽ ܾ݂݁݋ݎ݁ ݀݁ܽݐ݄ሻ, we have shown that 
ܲሺܹ ൏ ܵ|ࢨ, ࢽሻ ൌ ෍ ሾࡽሺ௠,௠ା௧
כିଵሻ
ஶ
௧כୀଵ
ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ                ሺ3.1ሻ 
By Delta method, if ݃൫݂ሺ݌ሻ൯ ൌ arcsin ඥ݌ then 
varሺarcsin ඥ݌ ሻ ൎ ൣ݃ᇱ൫݂ሺ݌ሻ൯ · ݂ᇱሺ݌ሻ൧
ଶ
ݒܽݎሺ݌̂ሻ                                                                    ሺ3.2ሻ                         
                              ൌ ቆ
1
ඥ1 െ ݌ଶ
·
1
2ඥ݌
ቇ
ଶ
ݒܽݎሺ݌̂ሻ                                                                     ሺ3.3ሻ 
                              ൌ ቆ
1
2ඥ݌ െ ݌ଷ
ቇ
௣ො
ଶ
ݒܽݎሺ݌̂ሻ                                                                              ሺ3.4ሻ 
                              ൌ ൤
1
4ሺ݌ െ ݌ଷሻ
൨
௣ො
ݒܽݎሺ݌̂ሻ                                                                                ሺ3.5ሻ 
Here we can estimate ݒܽݎሺ݌̂ሻ by a second round of Delta method. i.e. we need to start 
with Eq. (3.1) and the covariance matrix of the estimated parameter vector ࢼ෡. 
 
(ii) s.e. for ln ሺܱܴሻ using Delta method 
Let ݌ଵ ൌ Probability of dementia in group 1, and 
 ݌ଶ ൌ Probability of dementia in group 2, we have ܱܴ ൌ
೛భ
భష೛భ
೛మ
భష೛మ
.  
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By Delta method, 
ݒܽݎ ቌ
݌ଵ
1 െ ݌ଵ
݌ଶ
1 െ ݌ଶ
ቍ ൌ ቌ
1
݌ଶ
1 െ ݌ଶ
ቍ
ଶ
1
ሺ1 െ ݌ଵሻସ
ݒܽݎሺ݌ଵሻ ൅ ൬
݌ଵ
1 െ ݌ଵ
൰
ଶ
ቆെ
1
݌ଶ
ଶቇ
ଶ
ݒܽݎሺ݌ଶሻ 
                             െ2 ቆ
1 െ ݌ଶ
݌ଶ
ଷ ቇ ൤
݌ଵ
ሺ1 െ ݌ଵሻଷ
൨ ܿ݋ݒሺ݌ଵ, ݌ଶሻ                                                       ሺ3.6ሻ 
Then if we apply Delta method again with respect to the logarithm, we have 
ݒܽݎ ൮݈݊ ቌ
݌ଵ
1 െ ݌ଵ
݌ଶ
1 െ ݌ଶ
ቍ൲ ൌ ቌ
݌ଶ
1 െ ݌ଶ
݌ଵ
1 െ ݌ଵ
ቍ
ଶ
· ݒܽݎ ቌ
݌ଵ
1 െ ݌ଵ
݌ଶ
1 െ ݌ଶ
ቍ                                                       ሺ3.7ሻ 
ൎ ቈ
1
݌ଵ
ଶሺ1 െ ݌ଵሻଶ
቉
௣ොభ,௣ොమ
 ݒܽݎሺ݌̂ଵሻ ൅ ቈ
1
݌ଶ
ଶሺ1 െ ݌ଶሻଶ
቉
௣ොభ,௣ොమ
 ݒܽݎሺ݌̂ଶሻ                                                  
െ 2 ൤
1
݌ଵ݌ଶሺ1 െ ݌ଵሻሺ1 െ ݌ଶሻ
൨
௣ොభ,௣ොమ
 ܿ݋ݒሺ݌̂ଵ, ݌̂ଶሻ                                                                    ሺ3.8ሻ  
 
3.3.3 Formulating the covariance matrix 
Let ࡲሺ௠,௠ା௧כሻ ൌ ሺ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሻ ٔ ࡵଷ, then 
 ܲሺܹ ൏ ܵ|ࢨ, ࢽሻ ൌ ∑ ሾࡽሺ௠,௠ା௧כିଵሻஶ௧כୀଵ ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ 
                           ൌ ∑ ሾࡲሺ௠,௠ା௧כሻࡽሺ௠,௠ା௧כିଵሻஶ௧כୀଵ ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ 
Define ࡼሺ௠ሻ ൌ ∑ ሾࡲሺ௠,௠ା௧כሻࡽሺ௠,௠ା௧כିଵሻஶ௧כୀଵ ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿ ؠ ࡼሺ௠,ࢄሻ, ࢄ is the covariate 
matrix associated with ࡼ. For instance, given ࢄ ൌ ሺܽ݃݁ 80, ܣܱܲܧ4൅, ܧܦܷܥ ൏
16 ݕ݁ܽݎݏሻ, the three entries of ࡼሺ௠ሻ will be the probability of developing dementia 
before death for a certain subject with baseline age 80, apoe4 positive, less than 16 years 
of education starting from the initial state of intact cognition, M.C.I., and G.I., 
respectively.  
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Now let ࡼכሺ௠ሻ ൌ ൬ ࡼ
ሺ௠,ࢄሻ
ࡼሺ௠,ࢄ
כሻ൰. ࡼ
כሺ௠ሻ is a 6 ൈ 1 vector, which contains the probabilities 
from two different sets of covariates. We have 
ܿ݋ݒ൫ࡼכሺ௠ሻ൯ ൎ ൤
߲
߲ࢼ
ࡼכሺ௠ሻ൨ ܸሺࢼሻ ൤
߲
߲ࢼ
ࡼכሺ௠ሻ൨
௧
 
                            ൌ
ۏ
ێ
ێ
ێ
ۍ
߲
߲ࢼ
ࡼሺ௠,ࢄሻ
߲
߲ࢼ
ࡼሺ௠,ࢄ
כሻ
ے
ۑ
ۑ
ۑ
ې
ܸሺࢼሻ
ۏ
ێ
ێ
ێ
ۍ
߲
߲ࢼ
ࡼሺ௠,ࢄሻ
߲
߲ࢼ
ࡼሺ௠,ࢄ
כሻ
ے
ۑ
ۑ
ۑ
ې
௧
. 
In the following context we will address how to derive డ
డࢼ
ࡼሺ௠,ࢄሻ through matrix 
calculation. డ
డࢼ
ࡼሺ௠,ࢄ
כሻ can be solved analogously by simply substituting ࢄ with ࢄכ. 
Assume the process consists of 3 transient states (normal, MCI, GI) and 1 absorbing state 
(dementia), 
• denote డ
డࢼ
ݒ݁ܿሺࡽ௜ሻ by ࡭ሺ݅ሻ, ࡭ሺ݅ሻ is 9 ൈ ݈ (given ݈ is the length of ࢼ) 
• denote డ
డࢼ
ݒ݁ܿሺࡾ௜ሻ by ࡮ሺ݅ሻ, ࡮ሺ݅ሻ is 3 ൈ ݈  
• denote డ
డࢼ
ݒ݁ܿሺࡲ࢏ሻ by ࡯ሺ݅ሻ, ࡯ሺ݅ሻ is also 9 ൈ ݈  
Hence, we have 
߲
߲ࢼ
ࡼሺ௠ሻ ൌ
߲
߲ࢼ
ࡲଵࡾଵ ൅
߲
߲ࢼ
ࡲଶࡽଵࡾଶ ൅
߲
߲ࢼ
ࡲଷࡽଵࡽଶࡾଷ ൅ ڮ ൅
߲
߲ࢼ
ࡲ௞ ෑ ࡽ௜
௞ିଵ
௜ୀଵ
ࡾ௞ 
Introduce the vector transformation as follows: 
߲
߲ࢼ
ࡲଵࡾଵ ൌ ሺࡾଵ௧ ٔ ࡵଷሻ
߲
߲ࢼ
ݒ݁ܿሺࡲଵሻ ൅ ࡲଵ
߲
߲ࢼ
ݒ݁ܿሺࡾଵሻ ൌ ሺࡾଵ௧ ٔ ࡵଷሻ࡯ሺ1ሻ ൅ ࡲଵ࡮ሺ1ሻ 
which gives a 3 ൈ ݌ matrix; 
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߲
߲ࢼ
ࡲଶࡽଵࡾଶ ൌ ሺࡾଶ௧ ٔ ࡵଷሻ
߲
߲ࢼ
ሺࡲଶࡽଵሻ ൅ ሺࡲଶࡽଵሻ
߲
߲ࢼ
ݒ݁ܿሺࡾଶሻ 
ൌ ሺࡾଶ௧ ٔ ࡵଷሻሾሺࡽଵ௧ ٔ ࡵଷሻ࡯ሺ2ሻ ൅ ሺࡵଷ ٔ ࡲଶሻ࡭ሺ1ሻሿ ൅ ሺࡲଶࡽଵሻ࡮ሺ2ሻ 
also 3 ൈ ݌; 
Similarly, we can get  
߲
߲ࢼ
ࡲଷࡽଵࡽଶࡾଷ ൌ ሺࡾଷ௧ ٔ ࡵଷሻ
߲
߲ࢼ
ሺࡲଷࡽଵࡽଶሻ ൅ ሺࡲଷࡽଵࡽଶሻ
߲
߲ࢼ
ݒ݁ܿሺࡾଷሻ 
ൌ ሺࡾଷ௧ ٔ ࡵଷሻ ൤ሺࡽଶ௧ ٔ ࡵଷሻ
߲
߲ࢼ
ሺࡲଷࡽଵሻ ൅ ሺࡵଷ ٔ ࡲଷࡽଵሻ࡭ሺ2ሻ൨ ൅ ሺࡲଷࡽଵࡽଶሻ࡮ሺ3ሻ 
ൌ ሺࡾଷ௧ ٔ ࡵଷሻሾሺࡽଶ௧ ٔ ࡵଷሻሺሺࡽଵ௧ ٔ ࡵଷሻ࡯ሺ3ሻ ൅ ሺࡵଷ ٔ ࡲଷሻ࡭ሺ1ሻሻ ൅ ሺࡵଷ ٔ ࡲଷࡽଵሻ࡭ሺ2ሻሿ
൅ ሺࡲଷࡽଵࡽଶሻ࡮ሺ3ሻ 
Continuing in this manner, for general ݇ ൐ 1, the partials for a particular element 
డ
డࢼ
ࡲ ∏ ࡽ௜
௞ିଵ
௜ୀଵ ࡾ௞ can be formulated as 
ሺࡾ௞
௧ ٔ ࡵଷሻ ቎ෑ൫ࡽ௜
௧ ٔ ࡵଷ൯࡯ሺ݇ሻ ൅ ෍ ቌ ෑ ൫ࡽ௣௧ ٔ ࡵଷ൯
࢑ି૚
࢖ୀ࢏ା૚
ቍ ቌࡵଷ ٔ ࡲ௞ ෑ ࡽ௤
࢏ି૚
ࢗୀ૙
ቍ ࡭ሺ݅ሻ
࢑ି૚
࢏ୀ૚
௞ିଵ
௜ୀଵ
቏
൅ ࡲ௞ ෑ ࡽ௜
௞ିଵ
௜ୀଵ
࡮ሺ݇ሻ 
here, define ࡽ଴ ൌ ࡵଷ and ∏ ൫ࡽ௣௧ ٔ ࡵଷ൯௞ିଵ௣ୀ௞ ൌ ࡵଽ. 
 
Given the specifications of estimated transition matrix ࡼ and the cumulative distribution 
function of the residual survival time ܨௌ, we can decompose the parameter vector ࢼ into 
i) Transition parameters that are invariant across the rows (e.g. intercept, age, 
education, apoe4) 
ii) Transition parameters that vary across the rows (e.g. prior state indicator: prior1 
and prior2) 
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iii) Survival parameters (e.g. intercept, age at entry, apoe4 in the survival part) 
Assume again a process with 3 transient states (normal, MCI, GI) and 1 absorbing state 
(dementia). The ࡽ matrix can be specified as 
ۉ
ۈ
ۈ
ۈ
ۇ
1
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ
   
expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ
   
expሺࢄࢼଷ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଷሻ
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ
 
1
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ
   
expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ2ሻଶሻ
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ
   
expሺࢄࢼଷ ൅ ߚሺ݌ݎ݅݋ݎ2ሻଷሻ
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ
1
1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ
                               
expሺࢄࢼଶሻ
1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ
                               
expሺࢄࢼଷሻ
1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ
 
ی
ۋ
ۋ
ۋ
ۊ
 
 
ࡾ matrix can be specified similarly 
ۉ
ۈ
ۈ
ۈ
ۇ
expሺࢄࢼସ ൅ ߚሺ݌ݎ݅݋ݎ1ሻସሻ
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ
expሺࢄࢼସ ൅ ߚሺ݌ݎ݅݋ݎ2ሻସሻ
1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ
expሺࢄࢼସሻ
1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ ی
ۋ
ۋ
ۋ
ۊ
 
 
And in ࡲ matrix,  ܨ௜௜ ൌ 1 െ ܨௌ ൌ exp ሺെ݁ࢆࢼೞݏ௥ሻ, for ݅ ൌ 1,2,3; 
                            ܨ௜௝ ൌ 0, for ݅ ് ݆ ܽ݊݀ ݅, ݆ ൌ 1,2,3. 
 
For a ߚଶ א ࢼଶ which are the ߚ estimates associated with the transition to state 2 (MCI), 
the partial of individual element of ࡽ given ܺ is presented 
߲
߲ߚଶ
ܳଵଵ ൌ
െ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଶଵ ൌ
െ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ2ሻଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଷଵ ൌ
െ expሺࢄࢼଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ ሻଶ
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߲
߲ߚଶ
ܳଵଶ ൌ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻ௛ஷଶ ሻ ൈ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଶଶ ൌ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻ௛ஷଶ ሻ ൈ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ2ሻଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଷଶ ൌ
ሺ1 ൅ ∑ expሺࢄࢼ௛ሻ௛ஷଶ ሻ ൈ expሺࢄࢼଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଵଷ ൌ
െ expሺࢄࢼଷ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଷሻ ൈ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଶଷ ൌ
െ expሺࢄࢼଷ ൅ ߚሺ݌ݎ݅݋ݎ2ሻଷሻ ൈ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ2ሻଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ2ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚଶ
ܳଷଷ ൌ
െ expሺࢄࢼଷሻ ൈ expሺࢄࢼଶሻ ൈ ܺ
ሺ1 ൅ ∑ expሺࢄࢼ௛ሻସ௛ୀଶ ሻଶ
 
 
Other partials of the ߚ௛s invariant across rows can be formulated similarly. 
For a ߚሺ݌ݎ݅݋ݎ1ሻଶ the partial of individual element of ࡽ given ܺ is presented 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଵଵ ൌ
െ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଶଵ ൌ 0 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଷଵ ൌ 0 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଵଶ ൌ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻ௛ஷଶ ሻ ൈ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ ሻଶ
 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଶଶ ൌ 0 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଷଶ ൌ 0 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଵଷ ൌ
െ expሺࢄࢼଷ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଷሻ ൈ expሺࢄࢼଶ ൅ ߚሺ݌ݎ݅݋ݎ1ሻଶሻ
ሺ1 ൅ ∑ expሺࢄࢼ௛ ൅ ߚሺ݌ݎ݅݋ݎ1ሻ௛ሻସ௛ୀଶ ሻଶ
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߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଶଷ ൌ 0 
߲
߲ߚሺ݌ݎ݅݋ݎ1ሻଶ
ܳଷଷ ൌ 0 
Partials of ߚሺ݌ݎ݅݋ݎ1ሻ௛ and ߚሺ݌ݎ݅݋ݎ2ሻ௛, ݄ ൌ 2,3 can be formulated similarly. 
Partials of ߚs in i) and ii) with respect to ࡾ can be done analogously. 
For a ߚ௦ଶ א ࢼ௦ which are the ߚ estimates associated with the survival components, the 
partial of individual element of ࡲ given ܼ and ݏ is presented 
߲
߲ߚ௦ଶ
ܨ௜௜ ൌ െ݁ࢆࢼೞݏ௥ exp൫െ݁ࢆࢼೞݏ௥൯ · ܼ       ݂݋ݎ ݅ ൌ 1,2,3 
߲
߲ߚ௦ଶ
ܨ௜௝ ൌ 0      ݂݋ݎ ݅ ് ݆ ܽ݊݀ ݅, ݆ ൌ 1,2,3 
Other partials of the ࢼ௦ can be formulated similarly. 
Partials of ߚs in i) and ii) with respect to ࡲ are zeros.  
Partials of ߚs in iii) with respect to ࡽ and ࡾ are zeros. 
 
Back to Eq. (3.5), the variance term for ܽݎܿݏ݅݊ඥ݌ can be estimated by selecting the 
corresponding diagonal element ݒܽݎሺ݌̂ሻ  from the covariance matrix ܿ݋ݒ൫ࡼכሺ௠ሻ൯. 
Similarly, if we plug in ࢄ ൌ ሺܽ݃݁ 80, ܣܱܲܧ4൅, ܧܦܷܥ ൏ 16 ݕ݁ܽݎݏሻ and ࢄכ ൌ
ሺܽ݃݁ 80, ܣܱܲܧ4െ, ܧܦܷܥ ൏ 16 ݕ݁ܽݎݏሻ, we have ݒܽݎሺ݌̂ଵሻ, ݒܽݎሺ݌̂ଶሻ, and ܿ݋ݒሺ݌̂ଵ, ݌̂ଶሻ, 
and can then get the variance estimate for ln ሺܱܴ஺௉ைாସሻ of the two groups by Eq. (3.8). 
We have shown in the previous section that the statistics ܽݎܿݏ݅݊ඥ݌ and ln ሺܱܴሻ in our 
study satisfy the asymptotic normal assumption. Therefore, we can construct confidence 
intervals for ݌ and ܱܴ based on these statistics. 
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3.4 Application to the Nun Study Data 
In this section, we present the analysis of data in the Nun Study described in Section 2.4. 
The methodology of computing the probability that a subject develops dementia before 
death and thus the relative risk is now applied. The final analytic sample for parameter 
estimating consisted of 461 non-demented participants at baseline, of which almost half 
(n=225) died before converting to dementia. The 81 subjects diagnosed with dementia at 
their baseline visit were excluded.   
We let the transition probabilities depend on four covariates: age, the prior state (intact 
cognition or M.C.I. or G.I.), the APOE4 status (presence/absence of an apolipoprotein E-
4 allele), and levels of education. The residual survival times of the subjects are assumed 
to follow a parametric Weibull distribution that depends on two covariates age at entry 
and the APOE4 status. We further assume that a shared random intercept connects these 
two components transition and survival within the same subject. 
Recall that the model likelihood function is constructed as follows 
ܮ ൌ න ෑ ෑ ෑ ሺ ௦ܲ௩
௦ୀଵ…ଷ,
௩ୀଵ…ସ
௡೔
௟ୀଶ
ே
௜ୀଵ
ሺࢨ|ࢄ, ࢽሻሻఋ೤೔,೗షభ,ೞఋ೤೔,೗,ೡ ൈ ߨௌ೔ሺࢨ|ࢆ, ࢽሻ݀ܨሺࢽሻ 
Suppose there are N subjects in the study. The random vector ࢅ௜ ൌ ሺ ௜ܻଵ, … , ௜ܻ௡೔ሻ 
represents the cognitive states for the ith subject at ݊௜ different ordered assessments. We 
let ௦ܲ௩ denote the one step transition probability from state s to v. Here ௦ܲ௩ ൌ ௦ܲ௩
ሺ௠ሻ is 
dependent on time/age m. The residual survival time of the subject is assumed to follow a 
Weibull distribution. ߨௌ೔ denotes the probability of the ith subject with survival time ௜ܵ 
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failing from the competing risk of death. ௦ܲ௩ and ߨௌ೔ are determined by the commonly 
known risk factors for dementia and death, respectively. The dependence of the two 
components within the same subject is captured by the shared random effect ࢽ. 
Integrating over the whole support of the random effect, we thus obtain the likelihood 
function displayed above. 
Again the resultant integral can be approximated numerically using the Gauss quadrature 
method by assuming a normally distributed random effect with mean 0 and unknown 
variance ߪଶ. This part of the calculation is done using the SAS NLMIXED procedure. 
The maximum likelihood estimates are produced and presented in Table 3.1 below.  
Table 3.1 Parameter estimates for transition probabilities and residual survival in the Nun 
Study (Initial state: Intact cognition) 
Risk Factor MCI GI Dementia Residual Survival time 
Prior State: 
    Intact Cognition -1.1598* -3.7610* -5.2779* 
    MCI 0.7218* -2.3254* -1.9468* 
AGE 0.0949* 0.1746* 0.1723* 
EDUC < 16 yrs 1.5443* 1.5919* 1.4343* 
EDUC = 16 yrs 0.4723* 0.5041* 0.3792 
APOE4 STATUS 0.8422* 1.2971* 1.4184* 0.4238* 
AGE at ENTRY -0.2017* 
 
*Significant at P < 0.05 
Estimate of rate = 5.24; Estimate of sigma = 0.94 
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Table 3.2 Number of dementia and death by age in the Nun Study 
APOE4 –, EDUC ≥ 16 yrs, BASELINE = 1 
(Total = 117) 
 BEFORE 
AGE  80 85 90 95 95+
n1 (# of DEM) 0 2 3 5 2
n2 (# of DEAD) 0 12 29 22 5
݊ଵ ሺ݊ଵ ൅ ݊ଶሻ⁄   0 0.14 0.09 0.19 0.29
݊ଵ
݊
݊ଶ
݊
ൗ  0 0.17 0.10 0.23 0.40
 
 
APOE4 –, EDUC ≥ 16 yrs, BASELINE = 1, 2, 3 
(Total = 330) 
 BEFORE 
AGE  80 85 90 95 95+
n1 (# of DEM) 3 15 26 38 20
n2 (# of DEAD) 3 25 61 55 23
݊ଵ ሺ݊ଵ ൅ ݊ଶሻ⁄   0.5 0.375 0.30 0.41 0.47
݊ଵ
݊
݊ଶ
݊
ൗ  1 0.60 0.43 0.69 0.87
 
 
APOE4 –, EDUC ≥ 16 yrs, BASELINE = 1, 2, 3, 4 
(Total = 361) 
 BEFORE 
AGE  80 85 90 95 95+
n1 (# of DEM) 7 26 36 42 22
n2 (# of DEAD) 3 25 61 55 23
݊ଵ ሺ݊ଵ ൅ ݊ଶሻ⁄   0.7 0.51 0.37 0.43 0.49
݊ଵ
݊
݊ଶ
݊
ൗ  2.33 1.04 0.59 0.76 0.96
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Table 3.2 above summarizes the number of dementia and death before age 75, 80, 85, 90, 
95 and after among the largest subgroup (the low risk group: negative APOE4, college or 
above Education) in the Nun Study data. For the baseline intact nuns (baseline=1), the 
number of cases of dementia observed in the age intervals are small (no larger than 5). 
Including the baseline M.C.I. and G.I. (baseline=2,3), the value of ௡భ
௡భା௡మ
 decreases from 
age 85 to 90 and increases after 90. To further investigate the age effect, we add in a 
quadratic form of age to the original covariate vector and re-fit the model. It shows that 
the non-linear effect from age on transition is marginal since the associated Z-normal 
scores are only marginally significant at 5% level. These tables give a general idea how 
the probability of dementia before death and relative risk change with age in the data.  
Now consider the all subjects case. The empirical distribution of the probability of 
dementia before death in our data shows: in the low risk group, where the subjects have 
both risk factors being absent (negative APOE4 w/ high Education), the probability of 
dementia before death increases with age; while in the high risk groups, where the 
subjects have at least one of the risk factors being present (positive APOE4 w/ high 
Education, or negative APOE4 w/ low Education, or positive APOE4 w/ low Education), 
no significant age effect was found. The results are summarized as in Table 3.3 below. 
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Table 3.3 Summary of the age effect in the Nun Study (All subjects) 
Educ 
Pr of Dem 
before Death ≤ 12 yrs ≥ 16 yrs 
 
Apoe4 
 
+ 
 
Insufficient 
subjects 
 
No age 
effect 
 
– 
 
No age 
effect 
 
↑ by age 
 
Table 3.4 displays the estimated probabilities of dementia before death by different 
genetics and education group at age points 75, 80, 85, 90, and 95 with the initial state 
being intact cognition. These probabilities are calculated by replacing the unknown 
parameter vector with the corresponding MLEs from table 3.1.  
Table 3.4 Probability of dementia before death in the Nun Study 
(Initial state: Intact cognition) 
 AGE 
95 90 85 80 75 
APOE4 -, EDUC > 16 yrs 0.59 0.53 0.45 0.36 0.28 
APOE4 -, EDUC = 16 yrs 0.59 0.54 0.49 0.42 0.35 
APOE4 -, EDUC < 16 yrs 0.61 0.58 0.56 0.54 0.50 
APOE4 +, EDUC > 16 yrs 0.57 0.56 0.57 0.58 0.55 
APOE4 +, EDUC = 16 yrs 0.56 0.56 0.58 0.60 0.60 
APOE4 +, EDUC < 16 yrs 0.56 0.57 0.61 0.66 0.69 
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The result indicates that for intact cognitive subjects, having an apolipoprotein E-4 
present and low education increases the chance of dementia before death. In particular, 
(1) Subjects with APOE4 status being negative: 
The probability of converting to dementia before death increases with age. That is, a 
person is more likely to develop dementia at an elderly age. Education could help protect 
subjects from getting dementia. A person with lower education level would have greater 
chance of developing dementia than a same-aged person with higher education level. The 
education effect diminishes with the increase of age. More specifically, at age 75 the 
probability of dementia before death associated with less than 16 years of education is 
0.50, almost twice of that associated with over 16 years of education (0.28); while at age 
95 the difference is only 0.02. 
(2) Subjects with APOE4 status being positive: 
In general, subjects with positive APOE4 are much more likely to develop dementia at 
early ages (75, 80, and 85). A person at age 80 with positive APOE4 is almost same or 
more likely to convert to dementia as a person at age 95 with negative APOE4. The 
probability of dementia before death decreases with age for subjects having 16 years or 
less education. Among the highest education group, the change of the probabilities 
fluctuates by time and no monotone trend shows. The highly educated also retain lower 
risks of getting dementia except for those at age 95, when the probability is 0.57 slightly 
larger compared with the lower education levels (0.56).  However, the by-age difference 
is smaller in this case. 
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The estimated probabilities and odds ratios of dementia before death are computed by 
replacing the parameter vector with the corresponding maximum likelihood estimates 
from our model. For odds ratios, the comparison is made on the risk factor APOE 
(positive versus negative) for the same age and education group. The 90% confidence 
intervals for the probabilities and odds ratios are estimated using the Delta method as we 
discussed in the previous section. The results are presented in Figure 3.4 and 3.5. 
Figure 3.4 displays the estimated probabilities of developing dementia before death by 
APOE4, education, and at different age (75, 80, 85, 90, 95) with the initial state being 
intact cognition. The results show that in general the probabilities are only slightly 
changed by the genetics or education level in the elderly age groups (age 90 and age 95). 
In contrast the probabilities are more likely to be affected by these risk factors for nuns 
starting at a younger age. For nuns at age of 75-85, having an APOE4 present and low 
education increases the risk of getting dementia before death, and such influence from the 
genetics or education declines consistently with age. Particularly, in the youngest age 
group (age 75), the probability of developing dementia before death with APOE4 positive 
and lower than or equal to 12 years of education is more than twice higher than that with 
APOE4 negative and higher than 16 years of education. 
Figure 3.5 gives the estimated odds ratios of dementia before death in the two contrast 
APOE4 groups by education level and at age points (75, 80, 85, 90, 95) with the initial 
state being intact cognition. The results illustrate that having high education could 
somehow increase the odds ratio on APOE4, especially in the younger age groups. 
 
58 
 
Figure 3.4 Probabilities and 90% confidence intervals of dementia before death 
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Figure 3.5 Odds ratios and 90% confidence intervals of dementia before death (Risk 
factor: APOE4+ versus APOE4-) 
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3.5 Risk model 
The idea of replacing the original risk factors by a new indicator that represents the 
presence or absence status of certain risk factors for a given subject came directly from 
the results in the last section. As we found that among the subgroup of negative APOE4 
plus college or above education, which contains the majority of the participants in the 
study (n=330), there is a clear age effect on the probability of transition to dementia over 
time in contrast to the other three subgroups. Also, we hope it would help eliminate the 
observation insufficiency for low education by combining those subgroups with the risk 
indicator (n=4 for positive APOE4 w/ low education; n=44 for negative APOE4 w/ low 
education; and n=83 for positive APOE4 w/ high education). It is therefore of interest to 
compare the results under this “reduced” risk model and to look at the interval estimates 
of probabilities of developing dementia before death, which would now give more focus 
on the AGE effect.  
Base on the results from Chapter 2, we know that having positive APOE4 and low 
education are associated with higher risk of transition to dementia before death. We then 
consider grouping together the original risk factors APOE4 and EDUC by: first, re-define 
EDUC to be binary variable valued at 0 if having College or above education and 1 
otherwise; and second, newly define variable RISK as an indicator of the present/absent 
risk status of APOE4 and EDUC. 
Several models were compared which seemed substantively reasonable: 
Model I. As comparison, the main effects model with risk factors APOE4 (0 = 
negative; 1 = positive) and EDUC (0 = College or above; 1 = otherwise) 
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Model II. The main effects model with a two-level RISK (0 =  have neither of the 
risk factors present; 1 = have at least one of the two risk factors present) 
Model III. The main effects model with a three-level RISK (0 = have neither of the 
risk factors present; 1 =  have either one of the risk factors present; 2 = have both risk 
factors present) and 
Model IV. The model with 2-way interactions among AGE and RISK (0 = have 
neither of the risk factors present plus ൑ 85 years of age; 1 = otherwise) 
The fit criterions for these models are shown in Table 3.5 as follows. According to 
AIC/AICC, the three main effects models fit better than the interactions model. The BIC 
suggests that either the main effects model with a two-level RISK or the main effects 
model with a three-level RISK are reasonable; given this we opted for the simpler model 
– Model II, for ease of interpretation and parsimony. The model was fitted to the Nun 
study data and the results are presented in Table 3.6. The application found that APOE4 
is not a significant predictor for survival time. So it was excluded from the final RISK 
model. 
Table 3.5 Comparison of risk models on different fit criterions 
Risk Model   -2LogL AIC AICC BIC 
Main effects model (apoe4, educ) 
Main effects model (2-level risk) 
Main effects model (3-level risk) 
Interactions model (age*risk) 
5692.5 
5699.0 
5698.3 
5722.3 
5736.5 
5737.0 
5736.3 
5760.3 
5736.9 
5737.3 
5736.7 
5760.7 
5827.4 
5815.5 
5814.9 
5838.9 
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Table 3.6 Maximum likelihood estimates (SE) of model parameters in the Nun Study 
(Risk model; Base state: 1 = Intact Cognition) 
Risk Factors State Estimates
Std. 
Error Risk Factors State Estimates
Std. 
Error 
Markov chain       Weibull  survival       
Age 2 0.099* (0.016) Age at Entry - -0.204* (0.021) 
  3 0.177* (0.020) 
  4 0.172* (0.023) Rate  - 5.203* (0.306) 
Risk 2 0.899* (0.199)         
  3 1.222* (0.228) 
  4 1.299* (0.260)       
Prior states:       Sigma - 0.941* (0.106) 
Intact Cognition 2 -1.236* (0.333) 
  3 -3.830* (0.325) 
  4 -5.300* (0.544) 
Mild Cognitive 2 0.691* (0.326)         
       Impairment 3 -2.354* (0.305) 
  4 -1.963* (0.326)         
 
* Significant at P < 0.05 
 
We applied the Delta method again to produce the interval estimates for the probabilities 
of transition to dementia under the risk model. The simulated samples were generated to 
examine for normality and the results were quite similar to what we obtained under the 
previous model. The covariance matrix associated with the transition probabilities can be 
formulated analogously. The estimated mean probabilities with the 90% confidence 
intervals are displayed in Figure 3.6. These results are consistent with what we found in 
Section 3.3. Basically age plays an essential role on the transition probability to dementia 
for those subjects who have no potential genetics or education risk of the disease. In 
contrast, the subjects who have one or both of such risks show high probability of disease 
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at an earlier age of 75 while the impact of ageing is slight within the group. The 
probability of developing dementia increases steadily with age in the low risk group, and 
it will reach the same level of disease probability (p=0.6) at age 95, which is in average 
20 years later than those in the high risk group. 
 
Figure 3.6 Probabilities and 90% confidence intervals of dementia before death (Risk 
model) 
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3.6 Conclusion 
In the research of chronic diseases it is often of interest to study the absorption statistics 
that characterize the progression of disease associated with the effects of risk factors. 
Previous work showed that such statistics always exist in a time homogeneous Markov 
chain and they are directly related to the fundamental matrix. While in the 
nonhomogeneous case, proper assumptions are required to ensure the convergence of the 
corresponding matrix series. This chapter is focused on addressing the problem by 
accommodating the residual survival time of the subjects confounding in a 
nonhomogeneous Markov chain. The convergence status of the chain is examined and 
confirmed. Provide this condition, formulas are derived in computing (1) the probability 
of developing dementia before death and (2) the 90% confidence interval based on the 
Delta method. 
The results are illustrated with an application to the Nun study. The maximum likelihood 
estimates of the parameters (presented in Chapter 2) are applied to the computation of the 
absorption statistics and their confidence intervals. The analysis results indicate that age, 
education level, and APOE4 status are significant predictors of the transition 
probabilities. Low education and the presence of APOE4 increase the risk of converting 
to dementia before death. But the effect diminishes when the age increases. In addition, 
the odds ratio of dementia before death on APOE4 status (positive versus negative) 
increases as the level of education increases among younger age groups (age 75, 80, 85). 
 
 
Copyright © Liou Xu 2010 
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Chapter 4 : Summary and discussions 
 
4.1 Discussion of the model 
In medical applications, the response may refer to a disease state, and this multi-state 
process is often assumed to be Markov, which greatly simplifies the computation of the 
likelihood. We developed an improved parametric multi-state Markov model to model 
this type of longitudinal categorical response data.  
The model is based on Salazar’s multi-state Markov model (2007). Rather than defining 
death as a competing absorbing state to dementia, we treated the survival from death as a 
continuous variable. More specifically, we assumed that the residual survival time ௜ܵ of 
the ݅th subject follows a Weibull distribution ௜ܵ  ~ ܹܾ݁݅ݑ݈݈ሺݎ ൐ 0, ߤ௜ ൌ ݁ߟ0൅ࣁ
Ԣܼ݅൅ߛ݅ሻ, and 
the probability of this subject failing from the risk of death has the form: 
ߨሺ ௜ܵ ൌ ݐ௜|ࢨ, ࢽሻ ൌ ൣݎ݁ఎబାࣁ
ᇲ௓೔ାఊ೔ݐ௜
௥ିଵ݁ݔ݌൫െ݁ఎబାࣁ
ᇲ௓೔ାఊ೔ݐ௜
௥൯൧
ఛ೔
ൣ݁ݔ݌൫െ݁ఎబାࣁ
ᇲ௓೔ାఊ೔ݐ௜
௥൯൧
ଵିఛ೔
      ሺ4.1ሻ 
Here ߛ௜ is a shared random effect, ߬௜ is some indicator function valued at 1 if the subject 
died at time ݐ௜ and 0 otherwise, and ࢨ represents the vector of all the unknown 
parameters. 
The joint distribution of the categorical response vector ࢅ௜ conditional on the baseline 
state was determined by the product of the conditional distributions of ࢅ௜௝ given ࢅ௜௝ିଵ, 
assuming the first order Markov property holds. A multinomial logit parameterization 
could be applied to link these transition probabilities with the fixed and random risk 
factors, which are expressed as follows: 
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ܮ݋݃݅ݐ ܲ൫ ௜ܻ௝ ൌ ݒ ห ௜ܻ௝ିଵሻ ൌ ߙ௩ ൅ ࢄ௜௝ࢼ௩ ൅ ܿ௩ ௜ܻ௝ିଵ ൅ ߛ௜      ݂݋ݎ ݒ ൌ 2,3,4                     ሺ4.2ሻ 
Base on equations (4.1) and (4.2), the contribution of the ݅th participant to the likelihood 
function is 
ܮ௜ሺࢨ|ࢄ௜, ࢆ௜ሻ ൌ න ෑൈ ෑ ൫ ௦ܲ௩ሺࢨ|ࢄ௜, ࢽ௜ሻ൯
ఋ೤೔೗షభ,ೞఋ೤೔೗,ೡ ൈ ߨௌ೔ሺࢨ|ࢆ௜, ࢽ௜ሻ݀ܨሺࢽ௜ሻ      ሺ4.3ሻ
௦ୀଵڮଷ,
௩ୀଵڮସ
௡೔
௟ୀଶ
 
The functions ߨ and ܲ denote the left hand sides of (4.1) and (4.2) while ܨ denotes the 
cumulative distribution function for the shared random effect. The overall likelihood can 
be derived by evaluating the product of (4.3) across the N cohort participants under study. 
The resultant function was approximated using the Gauss-Hermite quadrature method to 
produce the maximum likelihood estimates of the parameters. 
The evaluation of the likelihood function of the proposed model requires a good choice 
for the distributional form of the survival term. Simulations in Chapter 2 showed that the 
model estimates were not sensitive to violations of the Weibull assumption in the case 
when lognormal is the true prior distribution. We considered four different case 
scenarios, under which two sets of comparisons were made to investigate: first, the 
effects of varying the sample size; and second, the effects of misspecification of the 
distributional form of survival from a possible alternative. The results indicated that when 
the prior distribution was correctly specified, increasing sample size would help improve 
the estimates in terms of reducing bias and MSE. On the other hand, only MSE was 
significantly affected by sample size if the distributional form of survival was 
misspecified. 
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4.2 Discussion of the transition probability 
To further investigate the long run behavior of the process, we considered the well known 
canonical form of the one-step transition matrix given by 
ࡼሺ௠,௠ାଵሻ ൌ ൤ࡽ
ሺ௠,௠ାଵሻ ࡾሺ௠,௠ାଵሻ
0 ࡵ
൨ 
We let ݉ being the initial starting time of the process. Suppose that there are ݎ absorbing 
states and ݐ transient states in the chain, then ࡽሺ௠,௠ାଵሻ is a square ݐ ൈ ݐ matrix of one-
step transition probabilities among the transient states, ࡾሺ௠,௠ାଵሻ is a ݐ ൈ ݎ matrix of one-
step transition probabilities from a transient state to an absorbing state. For a 
homogeneous Markov chain, the fundamental matrix ࡹ ൌ ሺࡵ െ ࡽሻିଵ is well-defined and 
its elements can be calculated explicitly from the converging series  
ࡹ ൌ ࡵ ൅ ࡽ ൅ ࡽଶ ൅ ڮ 
While in the nonhomogeneous case the fundamental matrix is replaced by the infinite 
series 
ࡹሺ௠ሻ ൌ ࡵ ൅ ࡽሺ௠,௠ାଵሻ ൅ ࡽሺ௠,௠ାଵሻࡽሺ௠ାଵ,௠ାଶሻ ൅ ڮ ൅ࡽሺ௠,௠ାଵሻ ڮ ࡽሺ௠ା௡ିଵ,௠ା௡ሻ ൅ ڮ 
By accommodating the residual life time of the subjects confounding in the chain, we 
derived the following formula for computing the probability of dementia before death for 
a given subject assuming initially started the process from state ݅ and baseline time ݉: 
ܲሺܹ ൏ ܵ|ࢨ, ࢽሻ ൌ ෍ ሾࡽሺ௠,௠ା௧
כିଵሻ
ஶ
௧כୀଵ
ࡾሺ௠ା௧
כିଵ,௠ା௧כሻሿሺ݅ሻ · ሾ1 െ ܨௌሺݐכ|ࢨ, ࢽሻሿ               ݂݋ݎ ݅ ൌ 1,2,3 
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Here ܹ is the minimum time it takes for the process to enter an absorbing state, and 
ܨௌሺ· |ࢨ, ࢽሻ is the cumulative distribution function of survival time ܵ. 
Yu et al. (2009) proved that under certain conditions the norm of the substochastic matrix 
ฮࡽሺ௠,௡ሻฮ converge to zero as ݊ ՜ ∞, which does not depend on the initial time ݉ or the 
states. Based on Platis et al.’s sufficient condition of convergence (1998) and the property 
of cumulative distribution functions, we showed that the probabilities of dementia before 
death converge with time.  
Another primary research interest in the Nun Study is to estimate the confidence intervals 
associated with the probabilities and odds ratios of developing dementia before death. 
Our approach by using the Delta method to estimate the corresponding standard errors 
and to construct the confidence intervals was introduced and illustrated in detail in 
Chapter 3. Such a technique is based upon the assumption of the asymptotic normality of 
the sampling distribution of the statistics. The assumption was carefully examined with 
large simulated samples. 
These results for nonhomogeneous Markov chains make it possible to study the effects of 
the risk factors on the long run behavior of the chain and in the process account for the 
impact of the competing event death. 
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4.3 Areas of future research 
The model proposed in this dissertation is likelihood based subject specific model 
conditional on the unobserved latent variables represented by the random effects. One 
appealing feature of the polychotomous logistic regression model with shared random 
effect approach is that it allows us to perform statistical inference for the risk factors by 
means of odds ratios. By fitting the model we were able to study the different roles of the 
predictors on a subject specific transition.  
Further extensions of the model may include that of allowing less strict assumptions 
about the association between the longitudinal responses and the time-to-event data. The 
general idea is to define separate but correlated latent variables ࢈ଵ and ࢈ଶ for ࢅଵ and ࢅଶ, 
and let ݂ሺ࢈ଵ, ࢈ଶሻ denote the joint density, often being bivariate normal. By assuming 
conditional independence of ࢅଵ and ࢅଶ given ሺ࢈ଵ, ࢈ଶሻ, the joint density of ࢅଵ and ࢅଶ can 
be obtained as 
݂ሺ࢟ଵ, ࢟ଶሻ ൌ ඵ ݂ሺ ࢟ଵ|࢈ଵሻ݂ሺ࢟ଶ|࢈ଶሻ݂ሺ࢈ଵ, ࢈ଶሻ݀࢈ଵ݀࢈ଶ. 
The dissertation looked at the impact of violations of the distributional assumption of the 
survival term over the parameter estimation through simulations. The results are 
conditional on other aspects of the model specifications such as the mean structure, 
random effects structure, and linkage function. It is therefore of interest to compare such 
parametric survival approach with a nonparametric or semiparametric likelihood 
approach for survival. A more flexible setting is to consider using proportional hazard 
model for the residual survival time of the subject depending on fixed effects ࢠ௜ and 
random effect ܾଶ௜ 
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݄௜ሺݐ|ܾଶ௜ሻ ൌ ݄଴ሺݐሻ expሺࢠ௜
ᇱߚ ൅ ߙᇱܾଶ௜ሻ 
with piecewise-constant baseline hazard (step-functions): ݄଴ሺݐሻ ൌ ∑ ߦ௤ܫሺݒ௤ିଵ ൏ ݐ ൑
ொ
௤ୀଵ
ݒ௤ሻ where 0 ൌ ݒ଴ ൏ ݒଵ ൏ ڮ ൏ ݒொ denotes a split of the time scale. 
In addition, research interests in this area can also be focused on misspecification of the 
linkage function of the model and procedures to assess goodness-of-fit for multi-state 
Markov models. Further investigation of the related model stability and verification of 
the model assumptions are both non-ignorable. 
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APPENDICES 
Appendix A: SAS code for model fitting 
libname thesis 'C:\Doc\My Doc_research'; 
ods output ParameterEstimates=est CovMatParmEst=cov; 
 
proc nlmixed data=nun4_M qpoints=1 cov;  
 
parms int1=0.01 int2=0.01 int3=0.01  
  age1=0.05 age2=0.05 age3=0.05  
  apo1=0.08 apo2=0.08 apo3=0.08  
      coll1=0.05 coll2=0.05 coll3=0.05   
  grad1=0.05 grad2=0.05 grad3=0.05   
      pri11=0.08 pri12=0.08 pri13=0.08  
  pri21=0.05 pri22=0.05 pri23=0.05  
       
  intb1=0.01 intb2=0.01 intb3=0.01 
      ageb1=0.05 ageb2=0.05 ageb3=0.05 
  apob1=0.08 apob2=0.08 apob3=0.08 
      collB1=0.05 collB2=0.05 collB3=0.05 
  gradB1=0.05 gradB2=0.05 gradB3=0.05 
 
  intc=0.01 entagec=0.05 apoc=0.05 
      ratc=0.5 
      sd=0.5; 
 
eta1=int1+age1*agec+apo1*apoe4+coll1*ed12+grad1*ed3+pri11*prior1+
pri21*prior2+u; 
eta2=int2+age2*agec+apo2*apoe4+coll2*ed12+grad2*ed3+pri12*prior1+
pri22*prior2+u; 
eta3=int3+age3*agec+apo3*apoe4+coll3*ed12+grad3*ed3+pri13*prior1+
pri23*prior2+u; 
 
exp_eta1=exp(eta1); 
exp_eta2=exp(eta2); 
exp_eta3=exp(eta3); 
den_eta=1+exp_eta1+ exp_eta2+exp_eta3; 
 
etab1=intb1+ageb1*agec+apob1*apoe4+collB1*ed12+gradB1*ed3+u; 
etab2=intb2+ageb2*agec+apob2*apoe4+collB2*ed12+gradB2*ed3+u; 
etab3=intb3+ageb3*agec+apob3*apoe4+collB3*ed12+gradB3*ed3+u; 
 
exp_etab1=exp(etab1); 
exp_etab2=exp(etab2); 
exp_etab3=exp(etab3); 
den_etab=1+exp_etab1+ exp_etab2+exp_etab3; 
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/* p1 denotes the baseline component */ 
if (priorstate=1) then p1=(1/den_etab)**baseline; 
else if (priorstate=2) then p1=(exp_etab1/den_etab)**baseline; 
else if (priorstate=3) then p1=(exp_etab2/den_etab)**baseline; 
else if (priorstate=4) then p1=(exp_etab3/den_etab)**baseline; 
 
/* p2 denotes the main transition process */ 
if (currentstate=1) then p2=(1/den_eta)**ind;  
else if (currentstate=2) then p2=(exp_eta1/den_eta)**ind;  
else if (currentstate=3) then p2=(exp_eta2/den_eta)**ind;  
else if (currentstate=4) then p2=(exp_eta3/den_eta)**ind; 
 
etac=intc+entagec*entrage+apoc*apoe4+u; 
exp_etac=exp(etac); 
 
/* p3 denotes the survival component */ 
if (indxi=1) then p3=(ratc*exp_etac*(survival**(ratc-1))*exp(-
exp_etac*(survival**ratc)))**(baseline*ind); 
else if (indxi=0) then p3=(exp(-
exp_etac*(survival**ratc)))**(baseline*ind); 
 
ll=log(p1*p2*p3);  
 
model currentstate ~ general (ll); 
random u ~ normal(0,sd*sd) subject=newid;  
run; 
 
 
data thesis.est; set est; run; 
data thesis.cov; set cov; run; 
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Appendix B: SAS macro data generation for simulations 
%MACRO data_gen(m,maxv); 
 
proc iml; 
 
START ptran(AGE, APOE, PRIOR1, PRIOR2, error); 
theta={-1.69 0.81 -1.05 0.07 0.19 0.21 0.27 0.39 1.62 0.58 -3.12 
-4.15 1.79 -2.43 -2.26}; 
agec=age-86; /* centered age */ 
p=j(4,4,0); 
 
p[1,1]=1/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[10]*PR
IOR1+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[11]*PR
IOR1+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[12]*PR
IOR1+error)); 
p[1,2]=exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[10]*PRIOR1+
error)/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[10]*PRIO
R1+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[11]*PRIO
R1+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[12]*PRIO
R1+error)); 
p[1,3]=exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[11]*PRIOR1+
error)/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[10]*PRIO
R1+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[11]*PRIO
R1+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[12]*PRIO
R1+error)); 
p[1,4]=exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[12]*PRIOR1+
error)/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[10]*PRIO
R1+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[11]*PRIO
R1+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[12]*PRIO
R1+error)); 
p[2,1]=1/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[13]*PR
IOR2+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[14]*PR
IOR2+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[15]*PR
IOR2+error)); 
p[2,2]=exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[13]*PRIOR2+
error)/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[13]*PRIO
R2+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[14]*PRIO
R2+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[15]*PRIO
R2+error));    
p[2,3]=exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[14]*PRIOR2+
error)/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[13]*PRIO
R2+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[14]*PRIO
R2+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[15]*PRIO
R2+error)); 
p[2,4]=exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[15]*PRIOR2+
error)/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+theta[13]*PRIO
R2+error)+exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+theta[14]*PRIO
R2+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+theta[15]*PRIO
R2+error)); 
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p[3,1]=1/(1+exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+error)+exp(t
heta[2]+theta[5]*AGEC+theta[8]*APOE+error)+exp(theta[3]+theta[6]*
AGEC+theta[9]*APOE+error)); 
p[3,2]=exp(theta[1]+theta[4]*AGEC+theta[7]*APOE+error)/(1+exp(the
ta[1]+theta[4]*AGEC+theta[7]*APOE+error)+exp(theta[2]+theta[5]*AG
EC+theta[8]*APOE+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+
error)); 
p[3,3]=exp(theta[2]+theta[5]*AGEC+theta[8]*APOE+error)/(1+exp(the
ta[1]+theta[4]*AGEC+theta[7]*APOE+error)+exp(theta[2]+theta[5]*AG
EC+theta[8]*APOE+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+
error)); 
p[3,4]=exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+error)/(1+exp(the
ta[1]+theta[4]*AGEC+theta[7]*APOE+error)+exp(theta[2]+theta[5]*AG
EC+theta[8]*APOE+error)+exp(theta[3]+theta[6]*AGEC+theta[9]*APOE+
error)); 
p[4,4]=1; 
    
return(p); 
FINISH ptran; 
 
start RANDMULTINOMIAL(N, NumTrials, Prob); 
    mP = rowvec(Prob); 
 d = ncol(mP);  
 if N<1 then do; 
 print "The requested number of observations should be at   
least 1:" N; stop; 
 end; 
     if NumTrials <1 then do; 
 print "The number of trials should be at least 1:"   
NumTrials; stop; 
 end; 
 if abs(1 - sum(Prob))>1e-8 then do; 
     print "The probabilities must sum to 1:" (sum(Prob)) 
[label="Sum"]; stop; 
     end; 
 if ncol(loc(Prob>0)) < d then do; 
 print "Each probability should be positive:" Prob; stop; 
 end; 
 b = mP; 
 order = d + 1 - rank(mP); 
 mP[order] = b;  
 X = j(n,d,0); 
 z = 0; 
 do i = 1 to N; 
  if d = 1 then do; 
   X[i] = NumTrials; 
  end; 
  else do; 
      m = NumTrials; 
      q = 1;    
      call randgen(z,'BINOM',m,mP[1]);  
   X[i,1] = z; 
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       do j = 2 to d-1 by 1 while ( m > 0 );   
       m = m - X[i,j-1]; 
    q = q - mP[j-1]; 
    newp = mP[j]/q; 
    call randgen(z,'BINOM',m,newp);  
    X[i,j] = z; 
   end; 
   X[i,d] = m - z ;  
  end; 
 end; 
 outX = X;  
 outX[ , 1:d] = X[, order]; 
 return(outX); 
finish; 
 
 
history=j(&m,&maxv,.);  
currentage=j(&m,&maxv,.); 
apoe4=j(&m,&maxv,.); 
survival=j(&m,&maxv,.); 
do i=1 to &m; 
   error=rannor(1234)*1; /* assign random effects */ 
                apoe=ranbin(0,1,.2); 
   storeapoe=apoe; 
   rate=5.08; 
   theta_surv={-14.27 0.26 -0.72}; 
   age=80;surv=0; 
   do until (surv>age); 
     age=rannor(0)*3+80; 
     if age>81 then entrage=1; else entrage=0; 
              
para=exp(theta_surv[1]+theta_surv[2]*apoe+theta
_surv[3]*entrage+error); 
     unisurv=ranuni(0); 
 surv=(1/(para##(1/rate)))*((-
log(unisurv))##(1/rate))+75; 
   end; 
   storesurv=surv; 
   storeage=age; 
   deltage=exp(0.18); 
   prior=1; 
   storehist=prior; 
    
   do j=1 to (&maxv-1); 
             age=age+deltage; 
    if prior=1 then prior1=1; else prior1=0; 
    if prior=2 then prior2=1; else prior2=0;  
    p=ptran(AGE, APOE, PRIOR1, PRIOR2, error);  
    prob=t(p[prior,]); 
    if prob={0,0,0,1} then current=4; 
 else current=RANDMULTINOMIAL(1, 1, 
prob)*{1,2,3,4}; 
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    storeage=storeage // age; 
    storeapoe=storeapoe // apoe; 
    storesurv=storesurv // surv; 
    storehist=storehist // current; 
    prior=current;            
    end; 
 
history=history // t(storehist);  
currentage=currentage // t(storeage); 
apoe4=apoe4//t(storeapoe); 
survival=survival // t(storesurv); 
end;  
    apoe4=apoe4[(&m+1):nrow(apoe4),]; 
    survival=survival[(&m+1):nrow(survival),]; 
    history=history[(&m+1):nrow(history),]; 
    currentage=round(currentage[(&m+1):nrow(currentage),],0.001); 
 id=t(1:&m); 
 do h=1 to &m; 
    do k=1 to (ncol(history)-1); 
    if history[h,k]=5 then do; 
        history[h,k+1:ncol(history)]=.; 
        currentage[h,k+1:ncol(currentage)]=.; 
              apoe4[h,k+1:ncol(apoe4)]=.; 
     survival[h,k+1:ncol(survival)]=.; 
         end; 
             if (history[h,k]=4 & (history[h,k+1]=1 | 
history[h,k+1]=2 | history[h,k+1]=3)) then do; 
        history[h,k+1:ncol(history)]=.; 
        currentage[h,k+1:ncol(currentage)]=.; 
     survival[h,k+1:ncol(survival)]=.; 
       end; 
    end; 
      end; 
 
data=id || history || currentage || apoe4 || survival; 
 
dataset1=id || history; 
dataset2=id || currentage ; 
dataset3=id || apoe4; 
dataset4=id || survival; 
 
create tmp1 from dataset1; append from dataset1; 
create tmp2 from dataset2; append from dataset2; 
create tmp3 from dataset3; append from dataset3; 
create tmp4 from dataset4; append from dataset4; 
 
proc sort data=tmp1;  by COL1; 
proc sort data=tmp2;  by COL1; 
proc sort data=tmp3;  by COL1; 
proc sort data=tmp4;  by COL1; 
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data a;  
retain id state; drop COL1; 
set tmp1; 
id=COL1; 
array xx(i) COL2-COL50; 
do i = 1 to 49; 
state=xx; 
output; 
end;run;   
 
data b;   
retain id age;drop COL1; 
set tmp2; 
id=COL1; 
array xx(i) COL2-COL50; 
do i = 1 to 49; 
age=xx; 
output; 
end;run; 
 
data c;  
retain id apoe; drop COL1; 
set tmp3; 
id=COL1; 
array xx(i) COL2-COL50; 
do i = 1 to 49; 
apoe=xx; 
output; 
end;run;  
 
data d;  
retain id survival; drop COL1; 
set tmp4; 
id=COL1; 
array xx(i) COL2-COL50; 
do i = 1 to 49; 
survival=xx; 
output; 
end;run;  
 
data randata;  
retain seq id state age apoe survival; 
merge a b c d; by id; 
keep seq id state age apoe survival; 
seq+1;  
if state^=.; 
run; 
proc sort; by seq; run; 
quit; 
%mend; 
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Appendix C: SAS macro random sample generation for normality check 
*nsim:number of iterations; 
*age:actual age of subjects; 
*apoe:1=positive,0=negative; 
*educ:1<=12yrs,13<=2<=15yrs,3=16yrs,4>=17yrs; 
*basestate:state at baseline(1,2,or3),default=1; 
 
libname thesis 'C:\Doc\My Doc_research'; 
 
%macro check_norm(nsim, age, apoe, educ, basestate); 
proc iml; 
use thesis.est; read all into A; 
use thesis.cov; read all into B; 
theta0=A[,1]; 
cov_theta0=B[,2:27]; 
randbeta=randnormal(&nsim,theta0,cov_theta0); 
 
ed12=0; 
if &educ=1 then ed12=1; 
if &educ=2 then ed12=1; 
ed3=0; 
if &educ=3 then ed3=1; 
ENTAGE=&AGE-82; 
 
prob_est=.; 
do ll=1 to &nsim; 
thetatmp=randbeta[ll,]`; 
theta=thetatmp[1:3] // thetatmp[16:21] // thetatmp[4:15]; 
theta2=thetatmp[22:25]; 
sd=thetatmp[26]; 
 
sum1=0; 
do ii=1 to 100; 
AGEC=&AGE-88; 
AGED=&AGE-75; 
QMAT=I(3);RMATEMP=0*j(3,1); 
 
do jj=1 to ii; 
M=j(3,3,0); E=j(3,3,1);  
M[1,1]=theta[1]+theta[4]+theta[10]*AGEC+theta[13]*&APOE+theta[16]
*ed12+theta[19]*ed3; 
M[1,2]=theta[2]+theta[5]+theta[11]*AGEC+theta[14]*&APOE+theta[17]
*ed12+theta[20]*ed3; 
M[1,3]=theta[3]+theta[6]+theta[12]*AGEC+theta[15]*&APOE+theta[18]
*ed12+theta[21]*ed3; 
M[2,1]=theta[1]+theta[7]+theta[10]*AGEC+theta[13]*&APOE+theta[16]
*ed12+theta[19]*ed3; 
M[2,2]=theta[2]+theta[8]+theta[11]*AGEC+theta[14]*&APOE+theta[17]
*ed12+theta[20]*ed3; 
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M[2,3]=theta[3]+theta[9]+theta[12]*AGEC+theta[15]*&APOE+theta[18]
*ed12+theta[21]*ed3; 
M[3,1]=theta[1]+theta[10]*AGEC+theta[13]*&APOE+theta[16]*ed12+the
ta[19]*ed3; 
M[3,2]=theta[2]+theta[11]*AGEC+theta[14]*&APOE+theta[17]*ed12+the
ta[20]*ed3; 
M[3,3]=theta[3]+theta[12]*AGEC+theta[15]*&APOE+theta[18]*ed12+the
ta[21]*ed3; 
 
E=exp(M); 
P=j(4,4,0); 
p[1,1]= 1/(1+E[1,+]); 
p[1,2]= E[1,1]/(1+E[1,+]); 
p[1,3]= E[1,2]/(1+E[1,+]); 
p[1,4]= E[1,3]/(1+E[1,+]); 
p[2,1]= 1/(1+E[2,+]); 
p[2,2]= E[2,1]/(1+E[2,+]); 
p[2,3]= E[2,2]/(1+E[2,+]); 
p[2,4]= E[2,3]/(1+E[2,+]); 
p[3,1]= 1/(1+E[3,+]); 
p[3,2]= E[3,1]/(1+E[3,+]); 
p[3,3]= E[3,2]/(1+E[3,+]); 
p[3,4]= E[3,3]/(1+E[3,+]); 
p[4,4]=1; 
 
Q=P[1:3,1:3]; 
R=P[1:3,4]; 
RMAT=QMAT*R; 
QMAT=QMAT*Q; 
RMATEMP=RMATEMP+RMAT; 
AGEC=AGEC+1; 
END; 
 
QMATEMP=QMAT*j(3,1); 
mu=exp(theta2[1]+theta2[2]*ENTAGE+theta2[3]*&APOE); 
delta_F1=exp(-mu#((AGED+ii)##theta2[4]))-exp(-
mu#((AGED+ii+1)##theta2[4]));  
sum_temp1=RMATEMP[&basestate]*delta_F1; 
sum1=sum1+sum_temp1; 
END; 
 
prob1=sum1; 
prob_est=prob_est//prob1; 
END; 
create output1 from prob_est; append from prob_est; 
quit; 
 
%mend; 
%ODDS1(nsim=10000, age=80, apoe=1, educ=2, basestate=1); 
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data output1; 
set output1; 
if col1 ne .;  
col2=log(col1); 
col3=col1/(1-col1); 
col4=log(col3); 
run; 
 
data output1; 
set output1; 
P=col1; 
lnP=col2; 
RR=col3; 
lnRR=col4; 
arsin_sqrtP=arsin(sqrt(P)); 
keep P lnP RR lnRR arsin_sqrtP; 
run; 
 
 
goptions htext=1.5; 
proc univariate data=output1; var P;  
histogram P / normal(color=yellow w=2 percents=20 40 60 80  
midpercents) 
cfill=blue midpoints=0 to 1.3 by 0.03 cframe=ligr;  
inset n normal(ksdpval) / pos=ne format=6.3; 
run; 
proc univariate data=output1; var arsin_sqrtP;  
histogram arsin_sqrtP / normal(color=yellow w=2 percents=20 40 60 
80 midpercents) 
cfill=blue midpoints=0.5 to 1.4 by 0.02 cframe=ligr;  
inset n normal(ksdpval) / pos=ne format=6.3; 
run; 
 
proc univariate data=output1;  
qqplot P lnP RR lnRR arsin_sqrtP / normal(mu=est sigma=est 
color=red l=2) 
square cframe=ligr; 
run; 
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Appendix D: SAS macro to compute partial derivatives for P(m) 
*age:actual age of subjects; 
*apoe:1=positive,0=negative; 
*educ:1<=12yrs,13<=2<=15yrs,3=16yrs,4>=17yrs; 
*basestate:state at baseline(1,2,or3),default=1; 
 
libname thesis 'C:\Doc\My Doc_research'; 
 
%macro PARTIAL1(age, apoe, educ, basestate); 
proc iml; 
use thesis1.est; read all into A; 
use thesis1.cov; read all into B; 
theta0=A[,1]; 
cov_theta0=B[,2:27]; 
theta=theta0[1:3] // theta0[16:21] // theta0[4:15]; 
theta2=theta0[22:25]; 
sd=theta0[26]; 
 
ed12=0; 
if &educ=1 then ed12=1; 
if &educ=2 then ed12=1; 
ed3=0; 
if &educ=3 then ed3=1; 
ENTAGE=&AGE-82; 
 
Q_0=I(3); 
AGEC=&AGE-88; 
AGED=&AGE-75; 
M=j(3,3,0); E=j(3,3,1);  
M[1,1]=theta[1]+theta[4]+theta[10]*AGEC+theta[13]*&APOE+theta[16]
*ed12+theta[19]*ed3; 
M[1,2]=theta[2]+theta[5]+theta[11]*AGEC+theta[14]*&APOE+theta[17]
*ed12+theta[20]*ed3; 
M[1,3]=theta[3]+theta[6]+theta[12]*AGEC+theta[15]*&APOE+theta[18]
*ed12+theta[21]*ed3; 
M[2,1]=theta[1]+theta[7]+theta[10]*AGEC+theta[13]*&APOE+theta[16]
*ed12+theta[19]*ed3; 
M[2,2]=theta[2]+theta[8]+theta[11]*AGEC+theta[14]*&APOE+theta[17]
*ed12+theta[20]*ed3; 
M[2,3]=theta[3]+theta[9]+theta[12]*AGEC+theta[15]*&APOE+theta[18]
*ed12+theta[21]*ed3; 
M[3,1]=theta[1]+theta[10]*AGEC+theta[13]*&APOE+theta[16]*ed12+the
ta[19]*ed3; 
M[3,2]=theta[2]+theta[11]*AGEC+theta[14]*&APOE+theta[17]*ed12+the
ta[20]*ed3; 
M[3,3]=theta[3]+theta[12]*AGEC+theta[15]*&APOE+theta[18]*ed12+the
ta[21]*ed3; 
 
E=exp(M); 
P=j(4,4,0); 
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p[1,1]= 1/(1+E[1,+]); 
p[1,2]= E[1,1]/(1+E[1,+]); 
p[1,3]= E[1,2]/(1+E[1,+]); 
p[1,4]= E[1,3]/(1+E[1,+]); 
p[2,1]= 1/(1+E[2,+]); 
p[2,2]= E[2,1]/(1+E[2,+]); 
p[2,3]= E[2,2]/(1+E[2,+]); 
p[2,4]= E[2,3]/(1+E[2,+]); 
p[3,1]= 1/(1+E[3,+]); 
p[3,2]= E[3,1]/(1+E[3,+]); 
p[3,3]= E[3,2]/(1+E[3,+]); 
p[3,4]= E[3,3]/(1+E[3,+]); 
p[4,4]=1; 
QMAT=P[1:3,1:3]; 
RMAT=P[1:3,4]; 
mu=exp(theta2[1]+theta2[2]*ENTAGE+theta2[3]*&APOE); 
F1=exp(-mu#((AGED+1)##theta2[4]));  
FMAT=F1#I(3); 
 
A=j(9,24,0); 
B=j(3,24,0); 
C=j(9,24,0); 
A[1,1]= -E[1,1]/((1+E[1,+])##2); 
A[2,1]= -E[2,1]/((1+E[2,+])##2); 
A[3,1]= -E[3,1]/((1+E[3,+])##2); 
A[4,1]= (1+E[1,+]-E[1,1])*E[1,1]/((1+E[1,+])##2); 
A[5,1]= (1+E[2,+]-E[2,1])*E[2,1]/((1+E[2,+])##2); 
A[6,1]= (1+E[3,+]-E[3,1])*E[3,1]/((1+E[3,+])##2); 
A[7,1]= -E[1,2]*E[1,1]/((1+E[1,+])##2); 
A[8,1]= -E[2,2]*E[2,1]/((1+E[2,+])##2); 
A[9,1]= -E[3,2]*E[3,1]/((1+E[3,+])##2); 
A[1,2]= -E[1,2]/((1+E[1,+])##2); 
A[2,2]= -E[2,2]/((1+E[2,+])##2); 
A[3,2]= -E[3,2]/((1+E[3,+])##2); 
A[4,2]= -E[1,1]*E[1,2]/((1+E[1,+])##2); 
A[5,2]= -E[2,1]*E[2,2]/((1+E[2,+])##2); 
A[6,2]= -E[3,1]*E[3,2]/((1+E[3,+])##2); 
A[7,2]= (1+E[1,+]-E[1,2])*E[1,2]/((1+E[1,+])##2); 
A[8,2]= (1+E[2,+]-E[2,2])*E[2,2]/((1+E[2,+])##2); 
A[9,2]= (1+E[3,+]-E[3,2])*E[3,2]/((1+E[3,+])##2); 
A[1,3]= -E[1,3]/((1+E[1,+])##2); 
A[2,3]= -E[2,3]/((1+E[2,+])##2); 
A[3,3]= -E[3,3]/((1+E[3,+])##2); 
A[4,3]= -E[1,1]*E[1,3]/((1+E[1,+])##2); 
A[5,3]= -E[2,1]*E[2,3]/((1+E[2,+])##2); 
A[6,3]= -E[3,1]*E[3,3]/((1+E[3,+])##2); 
A[7,3]= -E[1,2]*E[1,3]/((1+E[1,+])##2); 
A[8,3]= -E[2,2]*E[2,3]/((1+E[2,+])##2); 
A[9,3]= -E[3,2]*E[3,3]/((1+E[3,+])##2); 
A[1,4]= -E[1,1]/((1+E[1,+])##2); 
A[4,4]= (1+E[1,+]-E[1,1])*E[1,1]/((1+E[1,+])##2); 
A[7,4]= -E[1,2]*E[1,1]/((1+E[1,+])##2); 
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A[1,5]= -E[1,2]/((1+E[1,+])##2); 
A[4,5]= -E[1,1]*E[1,2]/((1+E[1,+])##2); 
A[7,5]= (1+E[1,+]-E[1,2])*E[1,2]/((1+E[1,+])##2); 
A[1,6]= -E[1,3]/((1+E[1,+])##2); 
A[4,6]= -E[1,1]*E[1,3]/((1+E[1,+])##2); 
A[7,6]= -E[1,2]*E[1,3]/((1+E[1,+])##2); 
A[2,7]= -E[2,1]/((1+E[2,+])##2); 
A[5,7]= (1+E[2,+]-E[2,1])*E[2,1]/((1+E[2,+])##2); 
A[8,7]= -E[2,2]*E[2,1]/((1+E[2,+])##2); 
A[2,8]= -E[2,2]/((1+E[2,+])##2); 
A[5,8]= -E[2,1]*E[2,2]/((1+E[2,+])##2); 
A[8,8]= (1+E[2,+]-E[2,2])*E[2,2]/((1+E[2,+])##2); 
A[2,9]= -E[2,3]/((1+E[2,+])##2); 
A[5,9]= -E[2,1]*E[2,3]/((1+E[2,+])##2); 
A[8,9]= -E[2,2]*E[2,3]/((1+E[2,+])##2); 
A[1,10]= -E[1,1]*AGEC/((1+E[1,+])##2); 
A[2,10]= -E[2,1]*AGEC/((1+E[2,+])##2); 
A[3,10]= -E[3,1]*AGEC/((1+E[3,+])##2); 
A[4,10]= (1+E[1,+]-E[1,1])*E[1,1]*AGEC/((1+E[1,+])##2); 
A[5,10]= (1+E[2,+]-E[2,1])*E[2,1]*AGEC/((1+E[2,+])##2); 
A[6,10]= (1+E[3,+]-E[3,1])*E[3,1]*AGEC/((1+E[3,+])##2); 
A[7,10]= -E[1,2]*E[1,1]*AGEC/((1+E[1,+])##2); 
A[8,10]= -E[2,2]*E[2,1]*AGEC/((1+E[2,+])##2); 
A[9,10]= -E[3,2]*E[3,1]*AGEC/((1+E[3,+])##2); 
A[1,11]= -E[1,2]*AGEC/((1+E[1,+])##2); 
A[2,11]= -E[2,2]*AGEC/((1+E[2,+])##2); 
A[3,11]= -E[3,2]*AGEC/((1+E[3,+])##2); 
A[4,11]= -E[1,1]*E[1,2]*AGEC/((1+E[1,+])##2); 
A[5,11]= -E[2,1]*E[2,2]*AGEC/((1+E[2,+])##2); 
A[6,11]= -E[3,1]*E[3,2]*AGEC/((1+E[3,+])##2); 
A[7,11]= (1+E[1,+]-E[1,2])*E[1,2]*AGEC/((1+E[1,+])##2); 
A[8,11]= (1+E[2,+]-E[2,2])*E[2,2]*AGEC/((1+E[2,+])##2); 
A[9,11]= (1+E[3,+]-E[3,2])*E[3,2]*AGEC/((1+E[3,+])##2); 
A[1,12]= -E[1,3]*AGEC/((1+E[1,+])##2); 
A[2,12]= -E[2,3]*AGEC/((1+E[2,+])##2); 
A[3,12]= -E[3,3]*AGEC/((1+E[3,+])##2); 
A[4,12]= -E[1,1]*E[1,3]*AGEC/((1+E[1,+])##2); 
A[5,12]= -E[2,1]*E[2,3]*AGEC/((1+E[2,+])##2); 
A[6,12]= -E[3,1]*E[3,3]*AGEC/((1+E[3,+])##2); 
A[7,12]= -E[1,2]*E[1,3]*AGEC/((1+E[1,+])##2); 
A[8,12]= -E[2,2]*E[2,3]*AGEC/((1+E[2,+])##2); 
A[9,12]= -E[3,2]*E[3,3]*AGEC/((1+E[3,+])##2); 
A[1,13]= -E[1,1]*&APOE/((1+E[1,+])##2); 
A[2,13]= -E[2,1]*&APOE/((1+E[2,+])##2); 
A[3,13]= -E[3,1]*&APOE/((1+E[3,+])##2); 
A[4,13]= (1+E[1,+]-E[1,1])*E[1,1]*&APOE/((1+E[1,+])##2); 
A[5,13]= (1+E[2,+]-E[2,1])*E[2,1]*&APOE/((1+E[2,+])##2); 
A[6,13]= (1+E[3,+]-E[3,1])*E[3,1]*&APOE/((1+E[3,+])##2); 
A[7,13]= -E[1,2]*E[1,1]*&APOE/((1+E[1,+])##2); 
A[8,13]= -E[2,2]*E[2,1]*&APOE/((1+E[2,+])##2); 
A[9,13]= -E[3,2]*E[3,1]*&APOE/((1+E[3,+])##2); 
A[1,14]= -E[1,2]*&APOE/((1+E[1,+])##2); 
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A[2,14]= -E[2,2]*&APOE/((1+E[2,+])##2); 
A[3,14]= -E[3,2]*&APOE/((1+E[3,+])##2); 
A[4,14]= -E[1,1]*E[1,2]*&APOE/((1+E[1,+])##2); 
A[5,14]= -E[2,1]*E[2,2]*&APOE/((1+E[2,+])##2); 
A[6,14]= -E[3,1]*E[3,2]*&APOE/((1+E[3,+])##2); 
A[7,14]= (1+E[1,+]-E[1,2])*E[1,2]*&APOE/((1+E[1,+])##2); 
A[8,14]= (1+E[2,+]-E[2,2])*E[2,2]*&APOE/((1+E[2,+])##2); 
A[9,14]= (1+E[3,+]-E[3,2])*E[3,2]*&APOE/((1+E[3,+])##2); 
A[1,15]= -E[1,3]*&APOE/((1+E[1,+])##2); 
A[2,15]= -E[2,3]*&APOE/((1+E[2,+])##2); 
A[3,15]= -E[3,3]*&APOE/((1+E[3,+])##2); 
A[4,15]= -E[1,1]*E[1,3]*&APOE/((1+E[1,+])##2); 
A[5,15]= -E[2,1]*E[2,3]*&APOE/((1+E[2,+])##2); 
A[6,15]= -E[3,1]*E[3,3]*&APOE/((1+E[3,+])##2); 
A[7,15]= -E[1,2]*E[1,3]*&APOE/((1+E[1,+])##2); 
A[8,15]= -E[2,2]*E[2,3]*&APOE/((1+E[2,+])##2); 
A[9,15]= -E[3,2]*E[3,3]*&APOE/((1+E[3,+])##2); 
A[1,16]= -E[1,1]*ed12/((1+E[1,+])##2); 
A[2,16]= -E[2,1]*ed12/((1+E[2,+])##2); 
A[3,16]= -E[3,1]*ed12/((1+E[3,+])##2); 
A[4,16]= (1+E[1,+]-E[1,1])*E[1,1]*ed12/((1+E[1,+])##2); 
A[5,16]= (1+E[2,+]-E[2,1])*E[2,1]*ed12/((1+E[2,+])##2); 
A[6,16]= (1+E[3,+]-E[3,1])*E[3,1]*ed12/((1+E[3,+])##2); 
A[7,16]= -E[1,2]*E[1,1]*ed12/((1+E[1,+])##2); 
A[8,16]= -E[2,2]*E[2,1]*ed12/((1+E[2,+])##2); 
A[9,16]= -E[3,2]*E[3,1]*ed12/((1+E[3,+])##2); 
A[1,17]= -E[1,2]*ed12/((1+E[1,+])##2); 
A[2,17]= -E[2,2]*ed12/((1+E[2,+])##2); 
A[3,17]= -E[3,2]*ed12/((1+E[3,+])##2); 
A[4,17]= -E[1,1]*E[1,2]*ed12/((1+E[1,+])##2); 
A[5,17]= -E[2,1]*E[2,2]*ed12/((1+E[2,+])##2); 
A[6,17]= -E[3,1]*E[3,2]*ed12/((1+E[3,+])##2); 
A[7,17]= (1+E[1,+]-E[1,2])*E[1,2]*ed12/((1+E[1,+])##2); 
A[8,17]= (1+E[2,+]-E[2,2])*E[2,2]*ed12/((1+E[2,+])##2); 
A[9,17]= (1+E[3,+]-E[3,2])*E[3,2]*ed12/((1+E[3,+])##2); 
A[1,18]= -E[1,3]*ed12/((1+E[1,+])##2); 
A[2,18]= -E[2,3]*ed12/((1+E[2,+])##2); 
A[3,18]= -E[3,3]*ed12/((1+E[3,+])##2); 
A[4,18]= -E[1,1]*E[1,3]*ed12/((1+E[1,+])##2); 
A[5,18]= -E[2,1]*E[2,3]*ed12/((1+E[2,+])##2); 
A[6,18]= -E[3,1]*E[3,3]*ed12/((1+E[3,+])##2); 
A[7,18]= -E[1,2]*E[1,3]*ed12/((1+E[1,+])##2); 
A[8,18]= -E[2,2]*E[2,3]*ed12/((1+E[2,+])##2); 
A[9,18]= -E[3,2]*E[3,3]*ed12/((1+E[3,+])##2); 
A[1,19]= -E[1,1]*ed3/((1+E[1,+])##2); 
A[2,19]= -E[2,1]*ed3/((1+E[2,+])##2); 
A[3,19]= -E[3,1]*ed3/((1+E[3,+])##2); 
A[4,19]= (1+E[1,+]-E[1,1])*E[1,1]*ed3/((1+E[1,+])##2); 
A[5,19]= (1+E[2,+]-E[2,1])*E[2,1]*ed3/((1+E[2,+])##2); 
A[6,19]= (1+E[3,+]-E[3,1])*E[3,1]*ed3/((1+E[3,+])##2); 
A[7,19]= -E[1,2]*E[1,1]*ed3/((1+E[1,+])##2); 
A[8,19]= -E[2,2]*E[2,1]*ed3/((1+E[2,+])##2); 
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A[9,19]= -E[3,2]*E[3,1]*ed3/((1+E[3,+])##2); 
A[1,20]= -E[1,2]*ed3/((1+E[1,+])##2); 
A[2,20]= -E[2,2]*ed3/((1+E[2,+])##2); 
A[3,20]= -E[3,2]*ed3/((1+E[3,+])##2); 
A[4,20]= -E[1,1]*E[1,2]*ed3/((1+E[1,+])##2); 
A[5,20]= -E[2,1]*E[2,2]*ed3/((1+E[2,+])##2); 
A[6,20]= -E[3,1]*E[3,2]*ed3/((1+E[3,+])##2); 
A[7,20]= (1+E[1,+]-E[1,2])*E[1,2]*ed3/((1+E[1,+])##2); 
A[8,20]= (1+E[2,+]-E[2,2])*E[2,2]*ed3/((1+E[2,+])##2); 
A[9,20]= (1+E[3,+]-E[3,2])*E[3,2]*ed3/((1+E[3,+])##2); 
A[1,21]= -E[1,3]*ed3/((1+E[1,+])##2); 
A[2,21]= -E[2,3]*ed3/((1+E[2,+])##2); 
A[3,21]= -E[3,3]*ed3/((1+E[3,+])##2); 
A[4,21]= -E[1,1]*E[1,3]*ed3/((1+E[1,+])##2); 
A[5,21]= -E[2,1]*E[2,3]*ed3/((1+E[2,+])##2); 
A[6,21]= -E[3,1]*E[3,3]*ed3/((1+E[3,+])##2); 
A[7,21]= -E[1,2]*E[1,3]*ed3/((1+E[1,+])##2); 
A[8,21]= -E[2,2]*E[2,3]*ed3/((1+E[2,+])##2); 
A[9,21]= -E[3,2]*E[3,3]*ed3/((1+E[3,+])##2); 
B[1,1]= -E[1,3]*E[1,1]/((1+E[1,+])##2); 
B[2,1]= -E[2,3]*E[2,1]/((1+E[2,+])##2); 
B[3,1]= -E[3,3]*E[3,1]/((1+E[3,+])##2); 
B[1,2]= -E[1,3]*E[1,2]/((1+E[1,+])##2); 
B[2,2]= -E[2,3]*E[2,2]/((1+E[2,+])##2); 
B[3,2]= -E[3,3]*E[3,2]/((1+E[3,+])##2); 
B[1,3]= (1+E[1,+]-E[1,3])*E[1,3]/((1+E[1,+])##2); 
B[2,3]= (1+E[2,+]-E[2,3])*E[2,3]/((1+E[2,+])##2); 
B[3,3]= (1+E[3,+]-E[3,3])*E[3,3]/((1+E[3,+])##2); 
B[1,4]= -E[1,3]*E[1,1]/((1+E[1,+])##2); 
B[1,5]= -E[1,3]*E[1,2]/((1+E[1,+])##2); 
B[1,6]= (1+E[1,+]-E[1,3])*E[1,3]/((1+E[1,+])##2); 
B[2,7]= -E[2,3]*E[2,1]/((1+E[2,+])##2); 
B[2,8]= -E[2,3]*E[2,2]/((1+E[2,+])##2); 
B[2,9]= (1+E[2,+]-E[2,3])*E[2,3]/((1+E[2,+])##2); 
B[1,10]= -E[1,3]*E[1,1]*AGEC/((1+E[1,+])##2); 
B[2,10]= -E[2,3]*E[2,1]*AGEC/((1+E[2,+])##2); 
B[3,10]= -E[3,3]*E[3,1]*AGEC/((1+E[3,+])##2); 
B[1,11]= -E[1,3]*E[1,2]*AGEC/((1+E[1,+])##2); 
B[2,11]= -E[2,3]*E[2,2]*AGEC/((1+E[2,+])##2); 
B[3,11]= -E[3,3]*E[3,2]*AGEC/((1+E[3,+])##2); 
B[1,12]= (1+E[1,+]-E[1,3])*E[1,3]*AGEC/((1+E[1,+])##2); 
B[2,12]= (1+E[2,+]-E[2,3])*E[2,3]*AGEC/((1+E[2,+])##2); 
B[3,12]= (1+E[3,+]-E[3,3])*E[3,3]*AGEC/((1+E[3,+])##2); 
B[1,13]= -E[1,3]*E[1,1]*&APOE/((1+E[1,+])##2); 
B[2,13]= -E[2,3]*E[2,1]*&APOE/((1+E[2,+])##2); 
B[3,13]= -E[3,3]*E[3,1]*&APOE/((1+E[3,+])##2); 
B[1,14]= -E[1,3]*E[1,2]*&APOE/((1+E[1,+])##2); 
B[2,14]= -E[2,3]*E[2,2]*&APOE/((1+E[2,+])##2); 
B[3,14]= -E[3,3]*E[3,2]*&APOE/((1+E[3,+])##2); 
B[1,15]= (1+E[1,+]-E[1,3])*E[1,3]*&APOE/((1+E[1,+])##2); 
B[2,15]= (1+E[2,+]-E[2,3])*E[2,3]*&APOE/((1+E[2,+])##2); 
B[3,15]= (1+E[3,+]-E[3,3])*E[3,3]*&APOE/((1+E[3,+])##2); 
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B[1,16]= -E[1,3]*E[1,1]*ed12/((1+E[1,+])##2); 
B[2,16]= -E[2,3]*E[2,1]*ed12/((1+E[2,+])##2); 
B[3,16]= -E[3,3]*E[3,1]*ed12/((1+E[3,+])##2); 
B[1,17]= -E[1,3]*E[1,2]*ed12/((1+E[1,+])##2); 
B[2,17]= -E[2,3]*E[2,2]*ed12/((1+E[2,+])##2); 
B[3,17]= -E[3,3]*E[3,2]*ed12/((1+E[3,+])##2); 
B[1,18]= (1+E[1,+]-E[1,3])*E[1,3]*ed12/((1+E[1,+])##2); 
B[2,18]= (1+E[2,+]-E[2,3])*E[2,3]*ed12/((1+E[2,+])##2); 
B[3,18]= (1+E[3,+]-E[3,3])*E[3,3]*ed12/((1+E[3,+])##2); 
B[1,19]= -E[1,3]*E[1,1]*ed3/((1+E[1,+])##2); 
B[2,19]= -E[2,3]*E[2,1]*ed3/((1+E[2,+])##2); 
B[3,19]= -E[3,3]*E[3,1]*ed3/((1+E[3,+])##2); 
B[1,20]= -E[1,3]*E[1,2]*ed3/((1+E[1,+])##2); 
B[2,20]= -E[2,3]*E[2,2]*ed3/((1+E[2,+])##2); 
B[3,20]= -E[3,3]*E[3,2]*ed3/((1+E[3,+])##2); 
B[1,21]= (1+E[1,+]-E[1,3])*E[1,3]*ed3/((1+E[1,+])##2); 
B[2,21]= (1+E[2,+]-E[2,3])*E[2,3]*ed3/((1+E[2,+])##2); 
B[3,21]= (1+E[3,+]-E[3,3])*E[3,3]*ed3/((1+E[3,+])##2); 
C[1,22]= (-mu#((AGED+1)##theta2[4]))*exp(mu#((AGED+1) 
##theta2[4])); 
C[5,22]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4])); 
C[9,22]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4])); 
C[1,23]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*ENTAGE; 
C[5,23]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*ENTAGE; 
C[9,23]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*ENTAGE; 
C[1,24]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*&APOE; 
C[5,24]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*&APOE; 
C[9,24]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*&APOE; 
AMAT=A;  
BMAT=B; 
CMAT=C; 
partemp=(RMAT`@I(3))*CMAT+FMAT*BMAT; 
AGEC=AGEC+1; 
 
do k=2 to 100; 
M=j(3,3,0); E=j(3,3,1);  
M[1,1]=theta[1]+theta[4]+theta[10]*AGEC+theta[13]*&APOE+theta[16]
*ed12+theta[19]*ed3; 
M[1,2]=theta[2]+theta[5]+theta[11]*AGEC+theta[14]*&APOE+theta[17]
*ed12+theta[20]*ed3; 
M[1,3]=theta[3]+theta[6]+theta[12]*AGEC+theta[15]*&APOE+theta[18]
*ed12+theta[21]*ed3; 
M[2,1]=theta[1]+theta[7]+theta[10]*AGEC+theta[13]*&APOE+theta[16]
*ed12+theta[19]*ed3; 
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M[2,2]=theta[2]+theta[8]+theta[11]*AGEC+theta[14]*&APOE+theta[17]
*ed12+theta[20]*ed3; 
M[2,3]=theta[3]+theta[9]+theta[12]*AGEC+theta[15]*&APOE+theta[18]
*ed12+theta[21]*ed3; 
M[3,1]=theta[1]+theta[10]*AGEC+theta[13]*&APOE+theta[16]*ed12+the
ta[19]*ed3; 
M[3,2]=theta[2]+theta[11]*AGEC+theta[14]*&APOE+theta[17]*ed12+the
ta[20]*ed3; 
M[3,3]=theta[3]+theta[12]*AGEC+theta[15]*&APOE+theta[18]*ed12+the
ta[21]*ed3; 
E=exp(M); 
P=j(4,4,0); 
p[1,1]= 1/(1+E[1,+]); 
p[1,2]= E[1,1]/(1+E[1,+]); 
p[1,3]= E[1,2]/(1+E[1,+]); 
p[1,4]= E[1,3]/(1+E[1,+]); 
p[2,1]= 1/(1+E[2,+]); 
p[2,2]= E[2,1]/(1+E[2,+]); 
p[2,3]= E[2,2]/(1+E[2,+]); 
p[2,4]= E[2,3]/(1+E[2,+]); 
p[3,1]= 1/(1+E[3,+]); 
p[3,2]= E[3,1]/(1+E[3,+]); 
p[3,3]= E[3,2]/(1+E[3,+]); 
p[3,4]= E[3,3]/(1+E[3,+]); 
p[4,4]=1; 
Q=P[1:3,1:3]; 
R=P[1:3,4]; 
QMAT=QMAT // Q; 
RMAT=RMAT // R; 
mu=exp(theta2[1]+theta2[2]*ENTAGE+theta2[3]*&APOE); 
F1=exp(-mu#((AGED+k)##theta2[4]));  
F=F1#I(3); 
FMAT=FMAT // F; 
 
A=j(9,24,0); 
B=j(3,24,0); 
C=j(9,24,0); 
A[1,1]= -E[1,1]/((1+E[1,+])##2); 
A[2,1]= -E[2,1]/((1+E[2,+])##2); 
A[3,1]= -E[3,1]/((1+E[3,+])##2); 
A[4,1]= (1+E[1,+]-E[1,1])*E[1,1]/((1+E[1,+])##2); 
A[5,1]= (1+E[2,+]-E[2,1])*E[2,1]/((1+E[2,+])##2); 
A[6,1]= (1+E[3,+]-E[3,1])*E[3,1]/((1+E[3,+])##2); 
A[7,1]= -E[1,2]*E[1,1]/((1+E[1,+])##2); 
A[8,1]= -E[2,2]*E[2,1]/((1+E[2,+])##2); 
A[9,1]= -E[3,2]*E[3,1]/((1+E[3,+])##2); 
A[1,2]= -E[1,2]/((1+E[1,+])##2); 
A[2,2]= -E[2,2]/((1+E[2,+])##2); 
A[3,2]= -E[3,2]/((1+E[3,+])##2); 
A[4,2]= -E[1,1]*E[1,2]/((1+E[1,+])##2); 
A[5,2]= -E[2,1]*E[2,2]/((1+E[2,+])##2); 
A[6,2]= -E[3,1]*E[3,2]/((1+E[3,+])##2); 
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A[7,2]= (1+E[1,+]-E[1,2])*E[1,2]/((1+E[1,+])##2); 
A[8,2]= (1+E[2,+]-E[2,2])*E[2,2]/((1+E[2,+])##2); 
A[9,2]= (1+E[3,+]-E[3,2])*E[3,2]/((1+E[3,+])##2); 
A[1,3]= -E[1,3]/((1+E[1,+])##2); 
A[2,3]= -E[2,3]/((1+E[2,+])##2); 
A[3,3]= -E[3,3]/((1+E[3,+])##2); 
A[4,3]= -E[1,1]*E[1,3]/((1+E[1,+])##2); 
A[5,3]= -E[2,1]*E[2,3]/((1+E[2,+])##2); 
A[6,3]= -E[3,1]*E[3,3]/((1+E[3,+])##2); 
A[7,3]= -E[1,2]*E[1,3]/((1+E[1,+])##2); 
A[8,3]= -E[2,2]*E[2,3]/((1+E[2,+])##2); 
A[9,3]= -E[3,2]*E[3,3]/((1+E[3,+])##2); 
A[1,4]= -E[1,1]/((1+E[1,+])##2); 
A[4,4]= (1+E[1,+]-E[1,1])*E[1,1]/((1+E[1,+])##2); 
A[7,4]= -E[1,2]*E[1,1]/((1+E[1,+])##2); 
A[1,5]= -E[1,2]/((1+E[1,+])##2); 
A[4,5]= -E[1,1]*E[1,2]/((1+E[1,+])##2); 
A[7,5]= (1+E[1,+]-E[1,2])*E[1,2]/((1+E[1,+])##2); 
A[1,6]= -E[1,3]/((1+E[1,+])##2); 
A[4,6]= -E[1,1]*E[1,3]/((1+E[1,+])##2); 
A[7,6]= -E[1,2]*E[1,3]/((1+E[1,+])##2); 
A[2,7]= -E[2,1]/((1+E[2,+])##2); 
A[5,7]= (1+E[2,+]-E[2,1])*E[2,1]/((1+E[2,+])##2); 
A[8,7]= -E[2,2]*E[2,1]/((1+E[2,+])##2); 
A[2,8]= -E[2,2]/((1+E[2,+])##2); 
A[5,8]= -E[2,1]*E[2,2]/((1+E[2,+])##2); 
A[8,8]= (1+E[2,+]-E[2,2])*E[2,2]/((1+E[2,+])##2); 
A[2,9]= -E[2,3]/((1+E[2,+])##2); 
A[5,9]= -E[2,1]*E[2,3]/((1+E[2,+])##2); 
A[8,9]= -E[2,2]*E[2,3]/((1+E[2,+])##2); 
A[1,10]= -E[1,1]*AGEC/((1+E[1,+])##2); 
A[2,10]= -E[2,1]*AGEC/((1+E[2,+])##2); 
A[3,10]= -E[3,1]*AGEC/((1+E[3,+])##2); 
A[4,10]= (1+E[1,+]-E[1,1])*E[1,1]*AGEC/((1+E[1,+])##2); 
A[5,10]= (1+E[2,+]-E[2,1])*E[2,1]*AGEC/((1+E[2,+])##2); 
A[6,10]= (1+E[3,+]-E[3,1])*E[3,1]*AGEC/((1+E[3,+])##2); 
A[7,10]= -E[1,2]*E[1,1]*AGEC/((1+E[1,+])##2); 
A[8,10]= -E[2,2]*E[2,1]*AGEC/((1+E[2,+])##2); 
A[9,10]= -E[3,2]*E[3,1]*AGEC/((1+E[3,+])##2); 
A[1,11]= -E[1,2]*AGEC/((1+E[1,+])##2); 
A[2,11]= -E[2,2]*AGEC/((1+E[2,+])##2); 
A[3,11]= -E[3,2]*AGEC/((1+E[3,+])##2); 
A[4,11]= -E[1,1]*E[1,2]*AGEC/((1+E[1,+])##2); 
A[5,11]= -E[2,1]*E[2,2]*AGEC/((1+E[2,+])##2); 
A[6,11]= -E[3,1]*E[3,2]*AGEC/((1+E[3,+])##2); 
A[7,11]= (1+E[1,+]-E[1,2])*E[1,2]*AGEC/((1+E[1,+])##2); 
A[8,11]= (1+E[2,+]-E[2,2])*E[2,2]*AGEC/((1+E[2,+])##2); 
A[9,11]= (1+E[3,+]-E[3,2])*E[3,2]*AGEC/((1+E[3,+])##2); 
A[1,12]= -E[1,3]*AGEC/((1+E[1,+])##2); 
A[2,12]= -E[2,3]*AGEC/((1+E[2,+])##2); 
A[3,12]= -E[3,3]*AGEC/((1+E[3,+])##2); 
A[4,12]= -E[1,1]*E[1,3]*AGEC/((1+E[1,+])##2); 
89 
 
A[5,12]= -E[2,1]*E[2,3]*AGEC/((1+E[2,+])##2); 
A[6,12]= -E[3,1]*E[3,3]*AGEC/((1+E[3,+])##2); 
A[7,12]= -E[1,2]*E[1,3]*AGEC/((1+E[1,+])##2); 
A[8,12]= -E[2,2]*E[2,3]*AGEC/((1+E[2,+])##2); 
A[9,12]= -E[3,2]*E[3,3]*AGEC/((1+E[3,+])##2); 
A[1,13]= -E[1,1]*&APOE/((1+E[1,+])##2); 
A[2,13]= -E[2,1]*&APOE/((1+E[2,+])##2); 
A[3,13]= -E[3,1]*&APOE/((1+E[3,+])##2); 
A[4,13]= (1+E[1,+]-E[1,1])*E[1,1]*&APOE/((1+E[1,+])##2); 
A[5,13]= (1+E[2,+]-E[2,1])*E[2,1]*&APOE/((1+E[2,+])##2); 
A[6,13]= (1+E[3,+]-E[3,1])*E[3,1]*&APOE/((1+E[3,+])##2); 
A[7,13]= -E[1,2]*E[1,1]*&APOE/((1+E[1,+])##2); 
A[8,13]= -E[2,2]*E[2,1]*&APOE/((1+E[2,+])##2); 
A[9,13]= -E[3,2]*E[3,1]*&APOE/((1+E[3,+])##2); 
A[1,14]= -E[1,2]*&APOE/((1+E[1,+])##2); 
A[2,14]= -E[2,2]*&APOE/((1+E[2,+])##2); 
A[3,14]= -E[3,2]*&APOE/((1+E[3,+])##2); 
A[4,14]= -E[1,1]*E[1,2]*&APOE/((1+E[1,+])##2); 
A[5,14]= -E[2,1]*E[2,2]*&APOE/((1+E[2,+])##2); 
A[6,14]= -E[3,1]*E[3,2]*&APOE/((1+E[3,+])##2); 
A[7,14]= (1+E[1,+]-E[1,2])*E[1,2]*&APOE/((1+E[1,+])##2); 
A[8,14]= (1+E[2,+]-E[2,2])*E[2,2]*&APOE/((1+E[2,+])##2); 
A[9,14]= (1+E[3,+]-E[3,2])*E[3,2]*&APOE/((1+E[3,+])##2); 
A[1,15]= -E[1,3]*&APOE/((1+E[1,+])##2); 
A[2,15]= -E[2,3]*&APOE/((1+E[2,+])##2); 
A[3,15]= -E[3,3]*&APOE/((1+E[3,+])##2); 
A[4,15]= -E[1,1]*E[1,3]*&APOE/((1+E[1,+])##2); 
A[5,15]= -E[2,1]*E[2,3]*&APOE/((1+E[2,+])##2); 
A[6,15]= -E[3,1]*E[3,3]*&APOE/((1+E[3,+])##2); 
A[7,15]= -E[1,2]*E[1,3]*&APOE/((1+E[1,+])##2); 
A[8,15]= -E[2,2]*E[2,3]*&APOE/((1+E[2,+])##2); 
A[9,15]= -E[3,2]*E[3,3]*&APOE/((1+E[3,+])##2); 
A[1,16]= -E[1,1]*ed12/((1+E[1,+])##2); 
A[2,16]= -E[2,1]*ed12/((1+E[2,+])##2); 
A[3,16]= -E[3,1]*ed12/((1+E[3,+])##2); 
A[4,16]= (1+E[1,+]-E[1,1])*E[1,1]*ed12/((1+E[1,+])##2); 
A[5,16]= (1+E[2,+]-E[2,1])*E[2,1]*ed12/((1+E[2,+])##2); 
A[6,16]= (1+E[3,+]-E[3,1])*E[3,1]*ed12/((1+E[3,+])##2); 
A[7,16]= -E[1,2]*E[1,1]*ed12/((1+E[1,+])##2); 
A[8,16]= -E[2,2]*E[2,1]*ed12/((1+E[2,+])##2); 
A[9,16]= -E[3,2]*E[3,1]*ed12/((1+E[3,+])##2); 
A[1,17]= -E[1,2]*ed12/((1+E[1,+])##2); 
A[2,17]= -E[2,2]*ed12/((1+E[2,+])##2); 
A[3,17]= -E[3,2]*ed12/((1+E[3,+])##2); 
A[4,17]= -E[1,1]*E[1,2]*ed12/((1+E[1,+])##2); 
A[5,17]= -E[2,1]*E[2,2]*ed12/((1+E[2,+])##2); 
A[6,17]= -E[3,1]*E[3,2]*ed12/((1+E[3,+])##2); 
A[7,17]= (1+E[1,+]-E[1,2])*E[1,2]*ed12/((1+E[1,+])##2); 
A[8,17]= (1+E[2,+]-E[2,2])*E[2,2]*ed12/((1+E[2,+])##2); 
A[9,17]= (1+E[3,+]-E[3,2])*E[3,2]*ed12/((1+E[3,+])##2); 
A[1,18]= -E[1,3]*ed12/((1+E[1,+])##2); 
A[2,18]= -E[2,3]*ed12/((1+E[2,+])##2); 
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A[3,18]= -E[3,3]*ed12/((1+E[3,+])##2); 
A[4,18]= -E[1,1]*E[1,3]*ed12/((1+E[1,+])##2); 
A[5,18]= -E[2,1]*E[2,3]*ed12/((1+E[2,+])##2); 
A[6,18]= -E[3,1]*E[3,3]*ed12/((1+E[3,+])##2); 
A[7,18]= -E[1,2]*E[1,3]*ed12/((1+E[1,+])##2); 
A[8,18]= -E[2,2]*E[2,3]*ed12/((1+E[2,+])##2); 
A[9,18]= -E[3,2]*E[3,3]*ed12/((1+E[3,+])##2); 
A[1,19]= -E[1,1]*ed3/((1+E[1,+])##2); 
A[2,19]= -E[2,1]*ed3/((1+E[2,+])##2); 
A[3,19]= -E[3,1]*ed3/((1+E[3,+])##2); 
A[4,19]= (1+E[1,+]-E[1,1])*E[1,1]*ed3/((1+E[1,+])##2); 
A[5,19]= (1+E[2,+]-E[2,1])*E[2,1]*ed3/((1+E[2,+])##2); 
A[6,19]= (1+E[3,+]-E[3,1])*E[3,1]*ed3/((1+E[3,+])##2); 
A[7,19]= -E[1,2]*E[1,1]*ed3/((1+E[1,+])##2); 
A[8,19]= -E[2,2]*E[2,1]*ed3/((1+E[2,+])##2); 
A[9,19]= -E[3,2]*E[3,1]*ed3/((1+E[3,+])##2); 
A[1,20]= -E[1,2]*ed3/((1+E[1,+])##2); 
A[2,20]= -E[2,2]*ed3/((1+E[2,+])##2); 
A[3,20]= -E[3,2]*ed3/((1+E[3,+])##2); 
A[4,20]= -E[1,1]*E[1,2]*ed3/((1+E[1,+])##2); 
A[5,20]= -E[2,1]*E[2,2]*ed3/((1+E[2,+])##2); 
A[6,20]= -E[3,1]*E[3,2]*ed3/((1+E[3,+])##2); 
A[7,20]= (1+E[1,+]-E[1,2])*E[1,2]*ed3/((1+E[1,+])##2); 
A[8,20]= (1+E[2,+]-E[2,2])*E[2,2]*ed3/((1+E[2,+])##2); 
A[9,20]= (1+E[3,+]-E[3,2])*E[3,2]*ed3/((1+E[3,+])##2); 
A[1,21]= -E[1,3]*ed3/((1+E[1,+])##2); 
A[2,21]= -E[2,3]*ed3/((1+E[2,+])##2); 
A[3,21]= -E[3,3]*ed3/((1+E[3,+])##2); 
A[4,21]= -E[1,1]*E[1,3]*ed3/((1+E[1,+])##2); 
A[5,21]= -E[2,1]*E[2,3]*ed3/((1+E[2,+])##2); 
A[6,21]= -E[3,1]*E[3,3]*ed3/((1+E[3,+])##2); 
A[7,21]= -E[1,2]*E[1,3]*ed3/((1+E[1,+])##2); 
A[8,21]= -E[2,2]*E[2,3]*ed3/((1+E[2,+])##2); 
A[9,21]= -E[3,2]*E[3,3]*ed3/((1+E[3,+])##2); 
B[1,1]= -E[1,3]*E[1,1]/((1+E[1,+])##2); 
B[2,1]= -E[2,3]*E[2,1]/((1+E[2,+])##2); 
B[3,1]= -E[3,3]*E[3,1]/((1+E[3,+])##2); 
B[1,2]= -E[1,3]*E[1,2]/((1+E[1,+])##2); 
B[2,2]= -E[2,3]*E[2,2]/((1+E[2,+])##2); 
B[3,2]= -E[3,3]*E[3,2]/((1+E[3,+])##2); 
B[1,3]= (1+E[1,+]-E[1,3])*E[1,3]/((1+E[1,+])##2); 
B[2,3]= (1+E[2,+]-E[2,3])*E[2,3]/((1+E[2,+])##2); 
B[3,3]= (1+E[3,+]-E[3,3])*E[3,3]/((1+E[3,+])##2); 
B[1,4]= -E[1,3]*E[1,1]/((1+E[1,+])##2); 
B[1,5]= -E[1,3]*E[1,2]/((1+E[1,+])##2); 
B[1,6]= (1+E[1,+]-E[1,3])*E[1,3]/((1+E[1,+])##2); 
B[2,7]= -E[2,3]*E[2,1]/((1+E[2,+])##2); 
B[2,8]= -E[2,3]*E[2,2]/((1+E[2,+])##2); 
B[2,9]= (1+E[2,+]-E[2,3])*E[2,3]/((1+E[2,+])##2); 
B[1,10]= -E[1,3]*E[1,1]*AGEC/((1+E[1,+])##2); 
B[2,10]= -E[2,3]*E[2,1]*AGEC/((1+E[2,+])##2); 
B[3,10]= -E[3,3]*E[3,1]*AGEC/((1+E[3,+])##2); 
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B[1,11]= -E[1,3]*E[1,2]*AGEC/((1+E[1,+])##2); 
B[2,11]= -E[2,3]*E[2,2]*AGEC/((1+E[2,+])##2); 
B[3,11]= -E[3,3]*E[3,2]*AGEC/((1+E[3,+])##2); 
B[1,12]= (1+E[1,+]-E[1,3])*E[1,3]*AGEC/((1+E[1,+])##2); 
B[2,12]= (1+E[2,+]-E[2,3])*E[2,3]*AGEC/((1+E[2,+])##2); 
B[3,12]= (1+E[3,+]-E[3,3])*E[3,3]*AGEC/((1+E[3,+])##2); 
B[1,13]= -E[1,3]*E[1,1]*&APOE/((1+E[1,+])##2); 
B[2,13]= -E[2,3]*E[2,1]*&APOE/((1+E[2,+])##2); 
B[3,13]= -E[3,3]*E[3,1]*&APOE/((1+E[3,+])##2); 
B[1,14]= -E[1,3]*E[1,2]*&APOE/((1+E[1,+])##2); 
B[2,14]= -E[2,3]*E[2,2]*&APOE/((1+E[2,+])##2); 
B[3,14]= -E[3,3]*E[3,2]*&APOE/((1+E[3,+])##2); 
B[1,15]= (1+E[1,+]-E[1,3])*E[1,3]*&APOE/((1+E[1,+])##2); 
B[2,15]= (1+E[2,+]-E[2,3])*E[2,3]*&APOE/((1+E[2,+])##2); 
B[3,15]= (1+E[3,+]-E[3,3])*E[3,3]*&APOE/((1+E[3,+])##2); 
B[1,16]= -E[1,3]*E[1,1]*ed12/((1+E[1,+])##2); 
B[2,16]= -E[2,3]*E[2,1]*ed12/((1+E[2,+])##2); 
B[3,16]= -E[3,3]*E[3,1]*ed12/((1+E[3,+])##2); 
B[1,17]= -E[1,3]*E[1,2]*ed12/((1+E[1,+])##2); 
B[2,17]= -E[2,3]*E[2,2]*ed12/((1+E[2,+])##2); 
B[3,17]= -E[3,3]*E[3,2]*ed12/((1+E[3,+])##2); 
B[1,18]= (1+E[1,+]-E[1,3])*E[1,3]*ed12/((1+E[1,+])##2); 
B[2,18]= (1+E[2,+]-E[2,3])*E[2,3]*ed12/((1+E[2,+])##2); 
B[3,18]= (1+E[3,+]-E[3,3])*E[3,3]*ed12/((1+E[3,+])##2); 
B[1,19]= -E[1,3]*E[1,1]*ed3/((1+E[1,+])##2); 
B[2,19]= -E[2,3]*E[2,1]*ed3/((1+E[2,+])##2); 
B[3,19]= -E[3,3]*E[3,1]*ed3/((1+E[3,+])##2); 
B[1,20]= -E[1,3]*E[1,2]*ed3/((1+E[1,+])##2); 
B[2,20]= -E[2,3]*E[2,2]*ed3/((1+E[2,+])##2); 
B[3,20]= -E[3,3]*E[3,2]*ed3/((1+E[3,+])##2); 
B[1,21]= (1+E[1,+]-E[1,3])*E[1,3]*ed3/((1+E[1,+])##2); 
B[2,21]= (1+E[2,+]-E[2,3])*E[2,3]*ed3/((1+E[2,+])##2); 
B[3,21]= (1+E[3,+]-E[3,3])*E[3,3]*ed3/((1+E[3,+])##2); 
C[1,22]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4])); 
C[5,22]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4])); 
C[9,22]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4])); 
C[1,23]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*ENTAGE; 
C[5,23]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*ENTAGE; 
C[9,23]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*ENTAGE; 
C[1,24]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*&APOE; 
C[5,24]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*&APOE; 
C[9,24]= (-mu#((AGED+1)##theta2[4]))*exp(-mu#((AGED+1) 
##theta2[4]))*&APOE; 
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AMAT=AMAT // A; 
BMAT=BMAT // B; 
CMAT=CMAT // C; 
AGEC=AGEC+1; 
END; 
 
 
TEMP_TOTAL=j(3,24,0); 
do kk=2 to 100; 
   TEMP_A=I(9); 
   TEMP_C=I(3); 
   TEMP_B=j(9,24,0); 
   do ii=1 to kk-1; 
       TEMP_B1=I(9); 
       TEMP_B2=I(3); 
       if ii=kk-1 then TEMP_B1=I(9); 
       else do pp=ii+1 to kk-1; 
       T_B1=QMAT[(3*pp-2):(3*pp),]`@I(3); 
       TEMP_B1=TEMP_B1*T_B1; 
       END; 
       do qq=1 to ii-1; 
       T_B2=QMAT[(3*qq-2):(3*qq),]; 
       TEMP_B2=TEMP_B2*T_B2; 
       END;  
   T_A=QMAT[(3*ii-2):(3*ii),]`@I(3); 
   TEMP_A=TEMP_A*T_A; 
   T_C=QMAT[(3*ii-2):(3*ii),]; 
   TEMP_C=TEMP_C*T_C; 
   S_B=TEMP_B1*(I(3)@(FMAT[(3*kk-2):(3*kk),]*TEMP_B2)) 
*AMAT[(9*ii-8):(9*ii),]; 
   TEMP_B=TEMP_B+S_B; 
   END; 
   TEMP_TS=(RMAT[(3*kk-2):(3*kk),]`@I(3))*(TEMP_A*CMAT[(9*kk-
8):(9*kk),]+TEMP_B)+FMAT[(3*kk-2):(3*kk),]*TEMP_C*BMAT[(3*kk-
2):(3*kk),]; 
   TEMP_TOTAL=TEMP_TOTAL+TEMP_TS; 
END; 
PAR_TOTAL=partemp+TEMP_TOTAL; 
print PAR_TOTAL; 
quit; 
%mend; 
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